In the last 12 months, insiders at BOSTON SCIENTIFIC CORP ($BSX) filed 851 transactions with the SEC: 1 open-market purchases totaling $4,515 and 100 sales totaling $228,678,714. Net insider sentiment: net selling.
BOSTON SCIENTIFIC CORP operates in the Surgical & medical instruments & apparatus industry (Industrial Applications and Services sector).
Most Active Insiders
- Mahoney Michael F (Chairman, President & CEO) — 101 transactions totaling $148,946,205
- Fitzgerald Joseph Michael (EVP & Group Pres, Cardiology) — 100 transactions totaling $72,187,081
- Brennan Daniel J. (EVP and CFO) — 66 transactions totaling $28,130,831
- Butcher Arthur C (EVP& Grp Pres, MedSurg & APAC) — 119 transactions totaling $19,579,450
- Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) — 55 transactions totaling $15,198,066
View all SEC Filings for BOSTON SCIENTIFIC CORP (BSX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | Pegus Cheryl | Director | A | Deferred Stock Units | 24 | $0.00 | 5,917.0000 | 1,494,500,000 | 0.41% | 0.00% |
| March 2, 2026 | Smith Cathy R | Director | A | Deferred Stock Units | 323 | $0.00 | 879.0000 | 1,494,500,000 | 58.09% | 0.00% |
| March 2, 2026 | Smith Cathy R | Director | A | Deferred Stock Units | 556 | $0.00 | 556.0000 | 1,494,500,000 | 9999.99% | 0.00% |
| March 2, 2026 | Weber Christophe Pierre | Director | A | Common Stock | 323 | $0.00 | 879.0000 | 1,494,500,000 | 58.09% | 0.00% |
| March 2, 2026 | Weber Christophe Pierre | Director | A | Common Stock | 556 | $0.00 | 556.0000 | 1,494,500,000 | 9999.99% | 0.00% |
| March 2, 2026 | Morano Susan E | Director | A | Common Stock | 24 | $0.00 | 6,663.0000 | 1,494,500,000 | 0.36% | 0.00% |
| March 1, 2026 | Woodworth Emily | SVP, Global Controller and CAO | M | Common Stock | 838 | $0.00 | 3,231.0000 | 1,494,500,000 | 35.02% | 0.00% |
| March 1, 2026 | Woodworth Emily | SVP, Global Controller and CAO | M | Restricted Stock Units | 838 | $0.00 | 1,676.0000 | 1,494,500,000 | 33.33% | 0.00% |
| March 1, 2026 | Woodworth Emily | SVP, Global Controller and CAO | F | Common Stock | 372 | $76.85 | 2,859.0000 | 1,494,500,000 | 11.51% | 0.00% |
| Feb. 19, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | I | Common Stock | 6851 | $75.76 | 75,997.0000 | 1,494,500,000 | 9.91% | 0.00% |
| Feb. 13, 2026 | Brown Vance R | EVP, GC and Corp. Secretary | A | Common Stock | 14804 | $0.00 | 64,013.0000 | 1,494,500,000 | 30.08% | 0.00% |
| Feb. 13, 2026 | Brown Vance R | EVP, GC and Corp. Secretary | A | Common Stock | 14804 | $0.00 | 49,209.0000 | 1,494,500,000 | 43.03% | 0.00% |
| Feb. 16, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Restricted Stock Units | 2546 | $0.00 | 0.0000 | 1,494,500,000 | 100.00% | 0.00% |
| Feb. 14, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Restricted Stock Units | 3173 | $0.00 | 3,173.0000 | 1,494,500,000 | 50.00% | 0.00% |
| Feb. 13, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Restricted Stock Units | 2237 | $0.00 | 6,713.0000 | 1,494,500,000 | 24.99% | 0.00% |
| Feb. 16, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | F | Common Stock | 1229 | $74.73 | 69,146.0000 | 1,494,500,000 | 1.75% | 0.00% |
| Feb. 16, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 2546 | $0.00 | 70,375.0000 | 1,494,500,000 | 3.75% | 0.00% |
| Feb. 14, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | F | Common Stock | 1535 | $74.73 | 67,829.0000 | 1,494,500,000 | 2.21% | 0.00% |
| Feb. 14, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 3173 | $0.00 | 69,364.0000 | 1,494,500,000 | 4.79% | 0.00% |
| Feb. 13, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | F | Common Stock | 25150 | $74.73 | 66,191.0000 | 1,494,500,000 | 27.53% | 0.00% |
| Feb. 13, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 2237 | $0.00 | 91,341.0000 | 1,494,500,000 | 2.51% | 0.00% |
| Feb. 13, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | A | Common Stock | 25380 | $0.00 | 89,104.0000 | 1,494,500,000 | 39.83% | 0.00% |
| Feb. 13, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | A | Common Stock | 25380 | $0.00 | 63,724.0000 | 1,494,500,000 | 66.19% | 0.00% |
| Feb. 16, 2026 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Restricted Stock Units | 3960 | $0.00 | 0.0000 | 1,494,500,000 | 100.00% | 0.00% |
| Feb. 14, 2026 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Restricted Stock Units | 4362 | $0.00 | 4,363.0000 | 1,494,500,000 | 49.99% | 0.00% |
| Feb. 13, 2026 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Restricted Stock Units | 2797 | $0.00 | 8,391.0000 | 1,494,500,000 | 25.00% | 0.00% |
| Feb. 16, 2026 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 1806 | $74.73 | 219,141.0000 | 1,494,500,000 | 0.82% | 0.00% |
| Feb. 16, 2026 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 3960 | $0.00 | 220,947.0000 | 1,494,500,000 | 1.82% | 0.00% |
| Feb. 14, 2026 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 1990 | $74.73 | 216,987.0000 | 1,494,500,000 | 0.91% | 0.00% |
| Feb. 14, 2026 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 4362 | $0.00 | 218,977.0000 | 1,494,500,000 | 2.03% | 0.00% |
| Feb. 13, 2026 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 33104 | $74.73 | 214,615.0000 | 1,494,500,000 | 13.36% | 0.00% |
| Feb. 13, 2026 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 2797 | $0.00 | 247,719.0000 | 1,494,500,000 | 1.14% | 0.00% |
| Feb. 13, 2026 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | A | Common Stock | 34898 | $0.00 | 244,922.0000 | 1,494,500,000 | 16.62% | 0.00% |
| Feb. 13, 2026 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | A | Common Stock | 34898 | $0.00 | 210,024.0000 | 1,494,500,000 | 19.93% | 0.00% |
| Feb. 16, 2026 | Mahoney Michael F | Chairman, President & CEO | M | Restricted Stock Units | 16265 | $0.00 | 0.0000 | 1,494,500,000 | 100.00% | 0.00% |
| Feb. 14, 2026 | Mahoney Michael F | Chairman, President & CEO | M | Restricted Stock Units | 16524 | $0.00 | 16,524.0000 | 1,494,500,000 | 50.00% | 0.00% |
| Feb. 13, 2026 | Mahoney Michael F | Chairman, President & CEO | M | Restricted Stock Units | 8832 | $0.00 | 26,498.0000 | 1,494,500,000 | 25.00% | 0.00% |
| Feb. 16, 2026 | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 7865 | $74.73 | 1,790,539.0000 | 1,494,500,000 | 0.44% | 0.00% |
| Feb. 16, 2026 | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 16265 | $0.00 | 1,798,404.0000 | 1,494,500,000 | 0.91% | 0.00% |
| Feb. 14, 2026 | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 7990 | $74.73 | 1,782,139.0000 | 1,494,500,000 | 0.45% | 0.00% |
| Feb. 14, 2026 | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 16524 | $0.00 | 1,790,129.0000 | 1,494,500,000 | 0.93% | 0.00% |
| Feb. 13, 2026 | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 132099 | $74.73 | 1,773,605.0000 | 1,494,500,000 | 6.93% | 0.01% |
| Feb. 13, 2026 | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 8832 | $0.00 | 1,905,704.0000 | 1,494,500,000 | 0.47% | 0.00% |
| Feb. 13, 2026 | Mahoney Michael F | Chairman, President & CEO | A | Common Stock | 132190 | $0.00 | 1,896,872.0000 | 1,494,500,000 | 7.49% | 0.01% |
| Feb. 13, 2026 | Mahoney Michael F | Chairman, President & CEO | A | Common Stock | 132190 | $0.00 | 1,764,682.0000 | 1,494,500,000 | 8.10% | 0.01% |
| Feb. 16, 2026 | O'Sullivan Miriam | SVP, Chief HR Officer | M | Restricted Stock Units | 990 | $0.00 | 0.0000 | 1,494,500,000 | 100.00% | 0.00% |
| Feb. 14, 2026 | O'Sullivan Miriam | SVP, Chief HR Officer | M | Restricted Stock Units | 1124 | $0.00 | 1,124.0000 | 1,494,500,000 | 50.00% | 0.00% |
| Feb. 13, 2026 | O'Sullivan Miriam | SVP, Chief HR Officer | M | Restricted Stock Units | 588 | $0.00 | 1,767.0000 | 1,494,500,000 | 24.97% | 0.00% |
| Feb. 16, 2026 | O'Sullivan Miriam | SVP, Chief HR Officer | F | Common Stock | 291 | $74.73 | 19,033.0000 | 1,494,500,000 | 1.51% | 0.00% |
| Feb. 16, 2026 | O'Sullivan Miriam | SVP, Chief HR Officer | M | Common Stock | 990 | $0.00 | 19,324.0000 | 1,494,500,000 | 5.40% | 0.00% |
| Feb. 14, 2026 | O'Sullivan Miriam | SVP, Chief HR Officer | F | Common Stock | 329 | $74.73 | 18,334.0000 | 1,494,500,000 | 1.76% | 0.00% |
| Feb. 14, 2026 | O'Sullivan Miriam | SVP, Chief HR Officer | M | Common Stock | 1124 | $0.00 | 18,663.0000 | 1,494,500,000 | 6.41% | 0.00% |
| Feb. 13, 2026 | O'Sullivan Miriam | SVP, Chief HR Officer | F | Common Stock | 200 | $74.73 | 17,539.0000 | 1,494,500,000 | 1.13% | 0.00% |
| Feb. 13, 2026 | O'Sullivan Miriam | SVP, Chief HR Officer | M | Common Stock | 588 | $0.00 | 17,739.0000 | 1,494,500,000 | 3.43% | 0.00% |
| Feb. 16, 2026 | Monson Jonathan | EVP and CFO | M | Restricted Stock Units | 990 | $0.00 | 0.0000 | 1,494,500,000 | 100.00% | 0.00% |
| Feb. 14, 2026 | Monson Jonathan | EVP and CFO | M | Restricted Stock Units | 1058 | $0.00 | 1,058.0000 | 1,494,500,000 | 50.00% | 0.00% |
| Feb. 13, 2026 | Monson Jonathan | EVP and CFO | M | Restricted Stock Units | 1766 | $0.00 | 5,300.0000 | 1,494,500,000 | 24.99% | 0.00% |
| Feb. 16, 2026 | Monson Jonathan | EVP and CFO | F | Common Stock | 440 | $74.73 | 37,986.0000 | 1,494,500,000 | 1.15% | 0.00% |
| Feb. 16, 2026 | Monson Jonathan | EVP and CFO | M | Common Stock | 990 | $0.00 | 38,426.0000 | 1,494,500,000 | 2.64% | 0.00% |
| Feb. 14, 2026 | Monson Jonathan | EVP and CFO | F | Common Stock | 470 | $74.73 | 37,436.0000 | 1,494,500,000 | 1.24% | 0.00% |
| Feb. 14, 2026 | Monson Jonathan | EVP and CFO | M | Common Stock | 1058 | $0.00 | 37,906.0000 | 1,494,500,000 | 2.87% | 0.00% |
| Feb. 13, 2026 | Monson Jonathan | EVP and CFO | F | Common Stock | 788 | $74.73 | 36,848.0000 | 1,494,500,000 | 2.09% | 0.00% |
| Feb. 13, 2026 | Monson Jonathan | EVP and CFO | M | Common Stock | 1766 | $0.00 | 37,636.0000 | 1,494,500,000 | 4.92% | 0.00% |
| Feb. 16, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | M | Restricted Stock Units | 905 | $0.00 | 0.0000 | 1,494,500,000 | 100.00% | 0.00% |
| Feb. 14, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | M | Restricted Stock Units | 1190 | $0.00 | 1,190.0000 | 1,494,500,000 | 50.00% | 0.00% |
| Feb. 13, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | M | Restricted Stock Units | 500 | $0.00 | 1,502.0000 | 1,494,500,000 | 24.98% | 0.00% |
| Feb. 16, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | F | Common Stock | 339 | $74.73 | 6,094.0000 | 1,494,500,000 | 5.27% | 0.00% |
| Feb. 16, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | M | Common Stock | 905 | $0.00 | 6,433.0000 | 1,494,500,000 | 16.37% | 0.00% |
| Feb. 14, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | F | Common Stock | 449 | $74.73 | 5,528.0000 | 1,494,500,000 | 7.51% | 0.00% |
| Feb. 14, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | M | Common Stock | 1190 | $0.00 | 5,977.0000 | 1,494,500,000 | 24.86% | 0.00% |
| Feb. 13, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | F | Common Stock | 199 | $74.73 | 4,787.0000 | 1,494,500,000 | 3.99% | 0.00% |
| Feb. 13, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | M | Common Stock | 500 | $0.00 | 4,986.0000 | 1,494,500,000 | 11.15% | 0.00% |
| Feb. 16, 2026 | Woodworth Emily | SVP, Global Controller and CAO | M | Restricted Stock Units | 637 | $0.00 | 0.0000 | 1,494,500,000 | 100.00% | 0.00% |
| Feb. 14, 2026 | Woodworth Emily | SVP, Global Controller and CAO | M | Restricted Stock Units | 661 | $0.00 | 661.0000 | 1,494,500,000 | 50.00% | 0.00% |
| Feb. 13, 2026 | Woodworth Emily | SVP, Global Controller and CAO | M | Restricted Stock Units | 1413 | $0.00 | 4,239.0000 | 1,494,500,000 | 25.00% | 0.00% |
| Feb. 16, 2026 | Woodworth Emily | SVP, Global Controller and CAO | F | Common Stock | 283 | $74.73 | 2,393.0000 | 1,494,500,000 | 10.58% | 0.00% |
| Feb. 16, 2026 | Woodworth Emily | SVP, Global Controller and CAO | M | Common Stock | 637 | $0.00 | 2,676.0000 | 1,494,500,000 | 31.24% | 0.00% |
| Feb. 14, 2026 | Woodworth Emily | SVP, Global Controller and CAO | F | Common Stock | 296 | $74.73 | 2,039.0000 | 1,494,500,000 | 12.68% | 0.00% |
| Feb. 14, 2026 | Woodworth Emily | SVP, Global Controller and CAO | M | Common Stock | 661 | $0.00 | 2,335.0000 | 1,494,500,000 | 39.49% | 0.00% |
| Feb. 13, 2026 | Woodworth Emily | SVP, Global Controller and CAO | M | Common Stock | 1413 | $0.00 | 2,364.0000 | 1,494,500,000 | 148.58% | 0.00% |
| Feb. 13, 2026 | Woodworth Emily | SVP, Global Controller and CAO | F | Common Stock | 690 | $74.73 | 1,674.0000 | 1,494,500,000 | 29.19% | 0.00% |
| Feb. 16, 2026 | Brown Vance R | EVP, GC and Corp. Secretary | M | Restricted Stock Units | 1839 | $0.00 | 0.0000 | 1,494,500,000 | 100.00% | 0.00% |
| Feb. 14, 2026 | Brown Vance R | EVP, GC and Corp. Secretary | M | Restricted Stock Units | 1851 | $0.00 | 1,851.0000 | 1,494,500,000 | 50.00% | 0.00% |
| Feb. 13, 2026 | Brown Vance R | EVP, GC and Corp. Secretary | M | Restricted Stock Units | 1118 | $0.00 | 3,357.0000 | 1,494,500,000 | 24.98% | 0.00% |
| Feb. 16, 2026 | Brown Vance R | EVP, GC and Corp. Secretary | F | Common Stock | 890 | $74.73 | 54,244.0000 | 1,494,500,000 | 1.61% | 0.00% |
| Feb. 16, 2026 | Brown Vance R | EVP, GC and Corp. Secretary | M | Common Stock | 1839 | $0.00 | 55,134.0000 | 1,494,500,000 | 3.45% | 0.00% |
| Feb. 14, 2026 | Brown Vance R | EVP, GC and Corp. Secretary | F | Common Stock | 895 | $74.73 | 53,295.0000 | 1,494,500,000 | 1.65% | 0.00% |
| Feb. 14, 2026 | Brown Vance R | EVP, GC and Corp. Secretary | M | Common Stock | 1851 | $0.00 | 54,190.0000 | 1,494,500,000 | 3.54% | 0.00% |
| Feb. 13, 2026 | Brown Vance R | EVP, GC and Corp. Secretary | F | Common Stock | 12792 | $74.73 | 52,339.0000 | 1,494,500,000 | 19.64% | 0.00% |
| Feb. 13, 2026 | Brown Vance R | EVP, GC and Corp. Secretary | M | Common Stock | 1118 | $0.00 | 65,131.0000 | 1,494,500,000 | 1.75% | 0.00% |
| Feb. 12, 2026 | Monson Jonathan | EVP and CFO | A | Stock Option (Right to Buy) | 27857 | $0.00 | 27,857.0000 | 1,494,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2026 | O'Sullivan Miriam | SVP, Chief HR Officer | M | Common Stock | 961 | $0.00 | 17,489.0000 | 1,494,500,000 | 5.81% | 0.00% |
| Feb. 12, 2026 | O'Sullivan Miriam | SVP, Chief HR Officer | F | Common Stock | 338 | $74.12 | 17,151.0000 | 1,494,500,000 | 1.93% | 0.00% |
| Feb. 12, 2026 | O'Sullivan Miriam | SVP, Chief HR Officer | M | Restricted Stock Units | 961 | $0.00 | 1,924.0000 | 1,494,500,000 | 33.31% | 0.00% |
| Feb. 12, 2026 | O'Sullivan Miriam | SVP, Chief HR Officer | A | Restricted Stock Units | 4722 | $0.00 | 4,722.0000 | 1,494,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2026 | O'Sullivan Miriam | SVP, Chief HR Officer | A | Stock Option (Right to Buy) | 11143 | $0.00 | 11,143.0000 | 1,494,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2026 | Woodworth Emily | SVP, Global Controller and CAO | M | Common Stock | 481 | $0.00 | 1,193.0000 | 1,494,500,000 | 67.56% | 0.00% |
| Feb. 12, 2026 | Woodworth Emily | SVP, Global Controller and CAO | F | Common Stock | 242 | $74.12 | 951.0000 | 1,494,500,000 | 20.29% | 0.00% |
| Feb. 12, 2026 | Woodworth Emily | SVP, Global Controller and CAO | M | Restricted Stock Units | 481 | $0.00 | 962.0000 | 1,494,500,000 | 33.33% | 0.00% |
| Feb. 12, 2026 | Woodworth Emily | SVP, Global Controller and CAO | A | Restricted Stock Units | 6071 | $0.00 | 6,071.0000 | 1,494,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2026 | Woodworth Emily | SVP, Global Controller and CAO | A | Stock Option (Right to Buy) | 5584 | $0.00 | 5,584.0000 | 1,494,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | M | Common Stock | 1058 | $0.00 | 4,943.0000 | 1,494,500,000 | 27.23% | 0.00% |
| Feb. 12, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | F | Common Stock | 457 | $74.12 | 4,486.0000 | 1,494,500,000 | 9.25% | 0.00% |
| Feb. 12, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | M | Restricted Stock Units | 1058 | $0.00 | 2,116.0000 | 1,494,500,000 | 33.33% | 0.00% |
| Feb. 12, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | A | Restricted Stock Units | 5059 | $0.00 | 5,059.0000 | 1,494,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | A | Stock Option (Right to Buy) | 11939 | $0.00 | 11,939.0000 | 1,494,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2026 | Monson Jonathan | EVP and CFO | M | Common Stock | 1154 | $0.00 | 36,443.0000 | 1,494,500,000 | 3.27% | 0.00% |
| Feb. 12, 2026 | Monson Jonathan | EVP and CFO | F | Common Stock | 573 | $74.12 | 35,870.0000 | 1,494,500,000 | 1.57% | 0.00% |
| Feb. 12, 2026 | Monson Jonathan | EVP and CFO | M | Restricted Stock Units | 1154 | $0.00 | 2,308.0000 | 1,494,500,000 | 33.33% | 0.00% |
| Feb. 12, 2026 | Monson Jonathan | EVP and CFO | A | Restricted Stock Units | 11805 | $0.00 | 11,805.0000 | 1,494,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2026 | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 13704 | $0.00 | 1,639,118.0000 | 1,494,500,000 | 0.84% | 0.00% |
| Feb. 12, 2026 | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 6626 | $74.12 | 1,632,492.0000 | 1,494,500,000 | 0.40% | 0.00% |
| Feb. 12, 2026 | Mahoney Michael F | Chairman, President & CEO | M | Restricted Stock Units | 13704 | $0.00 | 27,408.0000 | 1,494,500,000 | 33.33% | 0.00% |
| Feb. 12, 2026 | Mahoney Michael F | Chairman, President & CEO | A | Restricted Stock Units | 55652 | $0.00 | 55,652.0000 | 1,494,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2026 | Mahoney Michael F | Chairman, President & CEO | A | Stock Option (Right to Buy) | 131329 | $0.00 | 131,329.0000 | 1,494,500,000 | 9999.99% | 0.01% |
| Feb. 12, 2026 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 3462 | $0.00 | 176,738.0000 | 1,494,500,000 | 2.00% | 0.00% |
| Feb. 12, 2026 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 1612 | $74.12 | 175,126.0000 | 1,494,500,000 | 0.91% | 0.00% |
| Feb. 12, 2026 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Restricted Stock Units | 3462 | $0.00 | 6,924.0000 | 1,494,500,000 | 33.33% | 0.00% |
| Feb. 12, 2026 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | A | Restricted Stock Units | 18550 | $0.00 | 18,550.0000 | 1,494,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2026 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | A | Stock Option (Right to Buy) | 43776 | $0.00 | 43,776.0000 | 1,494,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 2692 | $0.00 | 39,646.0000 | 1,494,500,000 | 7.28% | 0.00% |
| Feb. 12, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | F | Common Stock | 1302 | $74.12 | 38,344.0000 | 1,494,500,000 | 3.28% | 0.00% |
| Feb. 12, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Restricted Stock Units | 2692 | $0.00 | 5,386.0000 | 1,494,500,000 | 33.33% | 0.00% |
| Feb. 12, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | A | Restricted Stock Units | 15178 | $0.00 | 15,178.0000 | 1,494,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | A | Stock Option (Right to Buy) | 35817 | $0.00 | 35,817.0000 | 1,494,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2026 | Brown Vance R | EVP, GC and Corp. Secretary | M | Common Stock | 1442 | $0.00 | 34,893.0000 | 1,494,500,000 | 4.31% | 0.00% |
| Feb. 12, 2026 | Brown Vance R | EVP, GC and Corp. Secretary | F | Common Stock | 488 | $74.12 | 34,405.0000 | 1,494,500,000 | 1.40% | 0.00% |
| Feb. 12, 2026 | Brown Vance R | EVP, GC and Corp. Secretary | M | Restricted Stock Units | 1442 | $0.00 | 2,886.0000 | 1,494,500,000 | 33.32% | 0.00% |
| Feb. 12, 2026 | Brown Vance R | EVP, GC and Corp. Secretary | A | Restricted Stock Units | 7420 | $0.00 | 7,420.0000 | 1,494,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2026 | Brown Vance R | EVP, GC and Corp. Secretary | A | Stock Option (Right to Buy) | 17510 | $0.00 | 17,510.0000 | 1,494,500,000 | 9999.99% | 0.00% |
| Feb. 2, 2026 | Mahoney Michael F | Chairman, President & CEO | S | Common Stock | 159701 | $93.49 | 1,625,414.0000 | 1,494,500,000 | 8.95% | 0.01% |
| Feb. 2, 2026 | Mahoney Michael F | Chairman, President & CEO | S | Common Stock | 1200 | $94.06 | 1,785,115.0000 | 1,494,500,000 | 0.07% | 0.00% |
| Feb. 2, 2026 | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 46347 | $27.09 | 1,786,315.0000 | 1,494,500,000 | 2.66% | 0.00% |
| Feb. 2, 2026 | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 49407 | $24.55 | 1,739,968.0000 | 1,494,500,000 | 2.92% | 0.00% |
| Feb. 2, 2026 | Mahoney Michael F | Chairman, President & CEO | M | Stock Option (Right to Buy) | 49407 | $0.00 | 98,814.0000 | 1,494,500,000 | 33.33% | 0.00% |
| Feb. 2, 2026 | Mahoney Michael F | Chairman, President & CEO | M | Stock Option (Right to Buy) | 46347 | $0.00 | 231,739.0000 | 1,494,500,000 | 16.67% | 0.00% |
| Dec. 1, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 1009 | $17.26 | 54,267.0000 | 1,495,500,000 | 1.89% | 0.00% |
| Dec. 1, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 3177 | $22.71 | 53,258.0000 | 1,495,500,000 | 6.34% | 0.00% |
| Dec. 1, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 6175 | $24.55 | 50,081.0000 | 1,495,500,000 | 14.06% | 0.00% |
| Dec. 1, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 6952 | $27.09 | 43,906.0000 | 1,495,500,000 | 18.81% | 0.00% |
| Dec. 1, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Stock Option (Right to Buy) | 3177 | $0.00 | 0.0000 | 1,495,500,000 | 100.00% | 0.00% |
| Dec. 1, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Stock Option (Right to Buy) | 6175 | $0.00 | 0.0000 | 1,495,500,000 | 100.00% | 0.00% |
| Dec. 1, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Stock Option (Right to Buy) | 1009 | $0.00 | 0.0000 | 1,495,500,000 | 100.00% | 0.00% |
| Dec. 1, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Stock Option (Right to Buy) | 6952 | $0.00 | 0.0000 | 1,495,500,000 | 100.00% | 0.00% |
| Dec. 1, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | S | Common Stock | 17313 | $101.55 | 36,954.0000 | 1,495,500,000 | 31.90% | 0.00% |
| Nov. 28, 2025 | O'Sullivan Miriam | SVP, Chief HR Officer | G | Common Stock | 260 | $0.00 | 16,528.0000 | 1,495,500,000 | 1.55% | 0.00% |
| Nov. 12, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | G | Common Stock | 690 | $0.00 | 182,886.0000 | 1,495,500,000 | 0.38% | 0.00% |
| Nov. 14, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | G | Common Stock | 9610 | $0.00 | 173,276.0000 | 1,495,500,000 | 5.25% | 0.00% |
| Nov. 6, 2025 | Zane Ellen M | Director | S | Common Stock | 12891 | $98.28 | 24,134.0000 | 1,495,500,000 | 34.82% | 0.00% |
| Nov. 3, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | S | Common Stock | 3600 | $100.75 | 229,976.0000 | 1,495,500,000 | 1.54% | 0.00% |
| Nov. 3, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Stock Option (Right to Buy) | 50000 | $0.00 | 0.0000 | 1,495,500,000 | 100.00% | 0.00% |
| Nov. 3, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | S | Common Stock | 29472 | $99.14 | 183,576.0000 | 1,495,500,000 | 13.83% | 0.00% |
| Nov. 3, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | S | Common Stock | 16928 | $99.76 | 213,048.0000 | 1,495,500,000 | 7.36% | 0.00% |
| Nov. 3, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 50000 | $26.15 | 233,576.0000 | 1,495,500,000 | 27.24% | 0.00% |
| Oct. 30, 2025 | Mahoney Michael F | Chairman, President & CEO | G | Common Stock | 149992 | $0.00 | 1,690,561.0000 | 1,495,500,000 | 8.15% | 0.01% |
| Oct. 29, 2025 | Zane Ellen M | Director | J | Common Stock | 12891 | $0.00 | 37,025.0000 | 1,495,500,000 | 53.41% | 0.00% |
| Oct. 29, 2025 | Mahoney Michael F | Chairman, President & CEO | G | Common Stock | 73996 | $0.00 | 1,840,553.0000 | 1,495,500,000 | 4.19% | 0.00% |
| Oct. 29, 2025 | Mahoney Michael F | Chairman, President & CEO | G | Common Stock | 88197 | $0.00 | 1,766,557.0000 | 1,495,500,000 | 5.25% | 0.01% |
| Oct. 28, 2025 | Zane Ellen M | Director | S | Common Stock | 2901 | $102.24 | 24,134.0000 | 1,495,500,000 | 10.73% | 0.00% |
| Oct. 27, 2025 | Zane Ellen M | Director | S | Common Stock | 9990 | $101.13 | 27,035.0000 | 1,495,500,000 | 26.98% | 0.00% |
| Oct. 1, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | S | Common Stock | 8245 | $98.91 | 225,331.0000 | 1,495,500,000 | 3.53% | 0.00% |
| Oct. 1, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 1,495,500,000 | 50.00% | 0.00% |
| Oct. 1, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | S | Common Stock | 41755 | $98.38 | 183,576.0000 | 1,495,500,000 | 18.53% | 0.00% |
| Oct. 1, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 50000 | $26.15 | 233,576.0000 | 1,495,500,000 | 27.24% | 0.00% |
| Sept. 2, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | S | Common Stock | 21830 | $104.89 | 211,746.0000 | 1,485,900,000 | 9.35% | 0.00% |
| Sept. 2, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Stock Option (Right to Buy) | 50000 | $0.00 | 100,000.0000 | 1,485,900,000 | 33.33% | 0.00% |
| Sept. 2, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | S | Common Stock | 28170 | $105.85 | 183,576.0000 | 1,485,900,000 | 13.30% | 0.00% |
| Sept. 2, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 50000 | $26.15 | 233,576.0000 | 1,485,900,000 | 27.24% | 0.00% |
| Aug. 1, 2025 | LUDWIG EDWARD J | Director | G | Common Stock | 500 | $0.00 | 17,979.0000 | 1,485,900,000 | 2.71% | 0.00% |
| Aug. 1, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Stock Option (Right to Buy) | 1009 | $0.00 | 1,009.0000 | 1,485,900,000 | 50.00% | 0.00% |
| Aug. 1, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Stock Option (Right to Buy) | 6952 | $0.00 | 6,952.0000 | 1,485,900,000 | 50.00% | 0.00% |
| Aug. 1, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | S | Common Stock | 17313 | $104.63 | 36,955.0000 | 1,485,900,000 | 31.90% | 0.00% |
| Aug. 1, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 1009 | $17.26 | 54,268.0000 | 1,485,900,000 | 1.89% | 0.00% |
| Aug. 1, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 3176 | $22.71 | 53,259.0000 | 1,485,900,000 | 6.34% | 0.00% |
| Aug. 1, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 6176 | $24.55 | 50,083.0000 | 1,485,900,000 | 14.07% | 0.00% |
| Aug. 1, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 6952 | $27.09 | 43,907.0000 | 1,485,900,000 | 18.81% | 0.00% |
| Aug. 1, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Stock Option (Right to Buy) | 50000 | $0.00 | 150,000.0000 | 1,485,900,000 | 25.00% | 0.00% |
| Aug. 1, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | S | Common Stock | 50000 | $104.63 | 183,576.0000 | 1,485,900,000 | 21.41% | 0.00% |
| Aug. 1, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Stock Option (Right to Buy) | 3176 | $0.00 | 3,177.0000 | 1,485,900,000 | 49.99% | 0.00% |
| Aug. 1, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Stock Option (Right to Buy) | 6176 | $0.00 | 6,175.0000 | 1,485,900,000 | 50.00% | 0.00% |
| Aug. 1, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 50000 | $26.15 | 233,576.0000 | 1,485,900,000 | 27.24% | 0.00% |
| Aug. 2, 2025 | Monson Jonathan | EVP and CFO | F | Common Stock | 528 | $105.41 | 35,289.0000 | 1,485,900,000 | 1.47% | 0.00% |
| Aug. 2, 2025 | Monson Jonathan | EVP and CFO | M | Restricted Stock Units | 1090 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| Aug. 2, 2025 | Monson Jonathan | EVP and CFO | M | Common Stock | 1090 | $0.00 | 35,817.0000 | 1,485,900,000 | 3.14% | 0.00% |
| July 29, 2025 | FUJIMORI YOSHIAKI | Director | S | Common Stock | 2901 | $106.99 | 2,081.0000 | 1,485,900,000 | 58.23% | 0.00% |
| July 25, 2025 | LUDWIG EDWARD J | Director | S | Common Stock | 4000 | $106.03 | 18,479.0000 | 1,485,900,000 | 17.79% | 0.00% |
| July 1, 2025 | Brown Vance R | SVP, GC and Corp. Secretary | M | Common Stock | 4036 | $0.00 | 35,403.0000 | 1,485,900,000 | 12.87% | 0.00% |
| July 1, 2025 | Brown Vance R | SVP, GC and Corp. Secretary | F | Common Stock | 1952 | $104.78 | 33,451.0000 | 1,485,900,000 | 5.51% | 0.00% |
| July 1, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | S | Common Stock | 50000 | $106.97 | 183,576.0000 | 1,485,900,000 | 21.41% | 0.00% |
| July 1, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Stock Option (Right to Buy) | 50000 | $0.00 | 200,000.0000 | 1,485,900,000 | 20.00% | 0.00% |
| July 1, 2025 | Brown Vance R | SVP, GC and Corp. Secretary | M | Restricted Stock Units | 4036 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| July 1, 2025 | Monson Jonathan | EVP and CFO | A | Restricted Stock Units | 8350 | $0.00 | 8,350.0000 | 1,485,900,000 | 9999.99% | 0.00% |
| July 1, 2025 | Monson Jonathan | EVP and CFO | A | Stock Option (Right to Buy) | 22173 | $0.00 | 22,173.0000 | 1,485,900,000 | 9999.99% | 0.00% |
| July 1, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 50000 | $26.15 | 233,576.0000 | 1,485,900,000 | 27.24% | 0.00% |
| June 4, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 56372 | $26.15 | 239,948.0000 | 1,485,900,000 | 30.71% | 0.00% |
| June 4, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Stock Option (Right to Buy) | 56372 | $0.00 | 250,000.0000 | 1,485,900,000 | 18.40% | 0.00% |
| June 4, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | S | Common Stock | 56372 | $102.88 | 183,576.0000 | 1,485,900,000 | 23.49% | 0.00% |
| June 2, 2025 | Mahoney Michael F | Chairman, President & CEO | S | Common Stock | 89921 | $103.39 | 1,678,360.0000 | 1,485,900,000 | 5.09% | 0.01% |
| June 2, 2025 | Mahoney Michael F | Chairman, President & CEO | S | Common Stock | 74522 | $104.05 | 1,768,281.0000 | 1,485,900,000 | 4.04% | 0.01% |
| June 2, 2025 | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 56212 | $17.26 | 1,793,396.0000 | 1,485,900,000 | 3.24% | 0.00% |
| June 2, 2025 | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 49407 | $24.55 | 1,842,803.0000 | 1,485,900,000 | 2.75% | 0.00% |
| June 2, 2025 | Mahoney Michael F | Chairman, President & CEO | M | Stock Option (Right to Buy) | 49407 | $0.00 | 148,221.0000 | 1,485,900,000 | 25.00% | 0.00% |
| June 2, 2025 | Mahoney Michael F | Chairman, President & CEO | M | Stock Option (Right to Buy) | 56212 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| May 29, 2025 | LUDWIG EDWARD J | Director | S | Common Stock | 4000 | $104.59 | 22,479.0000 | 1,485,900,000 | 15.11% | 0.00% |
| May 21, 2025 | Brown Vance R | SVP, GC and Corp. Secretary | S | Common Stock | 4826 | $106.42 | 31,367.0000 | 1,485,900,000 | 13.33% | 0.00% |
| May 8, 2025 | Pegus Cheryl | Director | A | Deferred Stock Units | 2081 | $0.00 | 5,288.0000 | 1,485,900,000 | 64.89% | 0.00% |
| May 8, 2025 | LUDWIG EDWARD J | Director | A | Common Stock | 2081 | $0.00 | 26,479.0000 | 1,485,900,000 | 8.53% | 0.00% |
| May 8, 2025 | Mega Jessica L | Director | A | Common Stock | 2081 | $0.00 | 8,235.0000 | 1,485,900,000 | 33.82% | 0.00% |
| May 8, 2025 | Morano Susan E | Director | A | Common Stock | 605 | $0.00 | 6,639.0000 | 1,485,900,000 | 10.03% | 0.00% |
| May 8, 2025 | Morano Susan E | Director | A | Common Stock | 2081 | $0.00 | 6,034.0000 | 1,485,900,000 | 52.64% | 0.00% |
| May 8, 2025 | Pegus Cheryl | Director | A | Deferred Stock Units | 605 | $0.00 | 5,893.0000 | 1,485,900,000 | 11.44% | 0.00% |
| May 8, 2025 | Habiger David C | Director | A | Common Stock | 2081 | $0.00 | 5,628.0000 | 1,485,900,000 | 58.67% | 0.00% |
| May 8, 2025 | Sununu John E | Director | A | Common Stock | 2081 | $0.00 | 54,723.0000 | 1,485,900,000 | 3.95% | 0.00% |
| May 8, 2025 | WICHMANN DAVID S | Director | A | Common Stock | 2081 | $0.00 | 41,582.0000 | 1,485,900,000 | 5.27% | 0.00% |
| May 8, 2025 | Zane Ellen M | Director | A | Common Stock | 2081 | $0.00 | 37,025.0000 | 1,485,900,000 | 5.96% | 0.00% |
| May 8, 2025 | FUJIMORI YOSHIAKI | Director | A | Common Stock | 2081 | $0.00 | 4,982.0000 | 1,485,900,000 | 71.73% | 0.00% |
| May 2, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | F | Common Stock | 1017 | $104.93 | 36,680.0000 | 1,485,900,000 | 2.70% | 0.00% |
| May 2, 2025 | Sorenson John Bradley | EVP, Global Operations | M | Common Stock | 4204 | $0.00 | 25,195.0000 | 1,485,900,000 | 20.03% | 0.00% |
| May 2, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Restricted Stock Units | 2102 | $0.00 | 2,102.0000 | 1,485,900,000 | 50.00% | 0.00% |
| May 2, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 2102 | $0.00 | 37,697.0000 | 1,485,900,000 | 5.91% | 0.00% |
| May 2, 2025 | Sorenson John Bradley | EVP, Global Operations | M | Restricted Stock Units | 4204 | $0.00 | 4,204.0000 | 1,485,900,000 | 50.00% | 0.00% |
| May 5, 2025 | Sorenson John Bradley | EVP, Global Operations | S | Common Stock | 4572 | $104.54 | 18,705.0000 | 1,485,900,000 | 19.64% | 0.00% |
| May 2, 2025 | Sorenson John Bradley | EVP, Global Operations | F | Common Stock | 1918 | $104.93 | 23,277.0000 | 1,485,900,000 | 7.61% | 0.00% |
| May 1, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Stock Option (Right to Buy) | 3177 | $0.00 | 6,353.0000 | 1,485,900,000 | 33.34% | 0.00% |
| May 1, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 6176 | $24.55 | 48,723.0000 | 1,485,900,000 | 14.52% | 0.00% |
| May 1, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 3177 | $22.71 | 51,900.0000 | 1,485,900,000 | 6.52% | 0.00% |
| May 1, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 1009 | $17.26 | 52,909.0000 | 1,485,900,000 | 1.94% | 0.00% |
| May 1, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | S | Common Stock | 17314 | $102.06 | 35,595.0000 | 1,485,900,000 | 32.72% | 0.00% |
| May 1, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Stock Option (Right to Buy) | 6952 | $0.00 | 13,904.0000 | 1,485,900,000 | 33.33% | 0.00% |
| May 1, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Stock Option (Right to Buy) | 1009 | $0.00 | 2,018.0000 | 1,485,900,000 | 33.33% | 0.00% |
| May 1, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 6952 | $27.09 | 42,547.0000 | 1,485,900,000 | 19.53% | 0.00% |
| May 1, 2025 | Mahoney Michael F | Chairman, President & CEO | M | Stock Option (Right to Buy) | 56212 | $0.00 | 56,212.0000 | 1,485,900,000 | 50.00% | 0.00% |
| May 1, 2025 | Mahoney Michael F | Chairman, President & CEO | S | Common Stock | 91282 | $102.13 | 1,737,184.0000 | 1,485,900,000 | 4.99% | 0.01% |
| May 1, 2025 | Mahoney Michael F | Chairman, President & CEO | S | Common Stock | 73161 | $102.92 | 1,828,466.0000 | 1,485,900,000 | 3.85% | 0.00% |
| May 1, 2025 | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 49407 | $24.55 | 1,901,627.0000 | 1,485,900,000 | 2.67% | 0.00% |
| May 1, 2025 | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 56212 | $17.26 | 1,852,220.0000 | 1,485,900,000 | 3.13% | 0.00% |
| May 1, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Stock Option (Right to Buy) | 6176 | $0.00 | 12,351.0000 | 1,485,900,000 | 33.34% | 0.00% |
| May 1, 2025 | Mahoney Michael F | Chairman, President & CEO | M | Stock Option (Right to Buy) | 49407 | $0.00 | 197,628.0000 | 1,485,900,000 | 20.00% | 0.00% |
| April 21, 2025 | Brown Vance R | SVP, GC and Corp. Secretary | S | Common Stock | 4826 | $95.09 | 36,193.0000 | 1,485,900,000 | 11.77% | 0.00% |
| April 1, 2025 | Mahoney Michael F | Chairman, President & CEO | S | Common Stock | 164442 | $100.01 | 1,796,008.0000 | 1,485,900,000 | 8.39% | 0.01% |
| April 1, 2025 | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 56211 | $17.26 | 1,911,043.0000 | 1,485,900,000 | 3.03% | 0.00% |
| April 1, 2025 | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 49407 | $24.55 | 1,960,450.0000 | 1,485,900,000 | 2.59% | 0.00% |
| April 1, 2025 | Mahoney Michael F | Chairman, President & CEO | M | Stock Option (Right to Buy) | 56211 | $0.00 | 112,424.0000 | 1,485,900,000 | 33.33% | 0.00% |
| April 1, 2025 | Mahoney Michael F | Chairman, President & CEO | M | Stock Option (Right to Buy) | 49407 | $0.00 | 247,035.0000 | 1,485,900,000 | 16.67% | 0.00% |
| March 21, 2025 | Brown Vance R | SVP, GC and Corp. Secretary | S | Common Stock | 4826 | $100.85 | 41,019.0000 | 1,485,900,000 | 10.53% | 0.00% |
| March 3, 2025 | Woodworth Emily | SVP, Global Controller and CAO | M | Stock Option (Right to Buy) | 5949 | $0.00 | 2,383.0000 | 1,485,900,000 | 71.40% | 0.00% |
| March 4, 2025 | Woodworth Emily | SVP, Global Controller and CAO | S | Common Stock | 482 | $104.63 | 432.0000 | 1,485,900,000 | 52.74% | 0.00% |
| March 3, 2025 | Woodworth Emily | SVP, Global Controller and CAO | S | Common Stock | 7149 | $104.97 | 914.0000 | 1,485,900,000 | 88.66% | 0.00% |
| March 3, 2025 | Woodworth Emily | SVP, Global Controller and CAO | M | Common Stock | 5949 | $37.50 | 8,063.0000 | 1,485,900,000 | 281.41% | 0.00% |
| Feb. 28, 2025 | Woodworth Emily | SVP, Global Controller and CAO | M | Common Stock | 7218 | $42.16 | 11,519.0000 | 1,485,900,000 | 167.82% | 0.00% |
| March 1, 2025 | Woodworth Emily | SVP, Global Controller and CAO | M | Restricted Stock Units | 837 | $0.00 | 2,514.0000 | 1,485,900,000 | 24.98% | 0.00% |
| Feb. 28, 2025 | Woodworth Emily | SVP, Global Controller and CAO | M | Stock Option (Right to Buy) | 7218 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| March 1, 2025 | Woodworth Emily | SVP, Global Controller and CAO | F | Common Stock | 355 | $103.79 | 2,114.0000 | 1,485,900,000 | 14.38% | 0.00% |
| March 1, 2025 | Woodworth Emily | SVP, Global Controller and CAO | M | Common Stock | 837 | $0.00 | 2,469.0000 | 1,485,900,000 | 51.29% | 0.00% |
| Feb. 28, 2025 | Woodworth Emily | SVP, Global Controller and CAO | S | Common Stock | 9887 | $101.13 | 1,632.0000 | 1,485,900,000 | 85.83% | 0.00% |
| Feb. 25, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | G | Common Stock | 340 | $0.00 | 183,576.0000 | 1,485,900,000 | 0.18% | 0.00% |
| Feb. 24, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | G | Common Stock | 1700 | $0.00 | 183,916.0000 | 1,485,900,000 | 0.92% | 0.00% |
| Feb. 24, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | G | Common Stock | 340 | $0.00 | 183,576.0000 | 1,485,900,000 | 0.19% | 0.00% |
| Feb. 25, 2025 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | S | Common Stock | 2688 | $104.00 | 25,766.0000 | 1,485,900,000 | 9.45% | 0.00% |
| Feb. 24, 2025 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | S | Common Stock | 4675 | $104.25 | 28,454.0000 | 1,485,900,000 | 14.11% | 0.00% |
| Feb. 24, 2025 | Zane Ellen M | Director | S | Common Stock | 13586 | $104.23 | 34,944.0000 | 1,485,900,000 | 28.00% | 0.00% |
| Feb. 21, 2025 | Brown Vance R | SVP, GC and Corp. Secretary | S | Common Stock | 4826 | $104.64 | 45,845.0000 | 1,485,900,000 | 9.52% | 0.00% |
| Feb. 20, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | G | Common Stock | 1000 | $0.00 | 185,276.0000 | 1,485,900,000 | 0.54% | 0.00% |
| Feb. 19, 2025 | Brennan Daniel J. | EVP and CFO | M | Common Stock | 18533 | $24.55 | 251,151.0000 | 1,485,900,000 | 7.97% | 0.00% |
| Feb. 18, 2025 | Brennan Daniel J. | EVP and CFO | S | Common Stock | 2900 | $104.08 | 247,248.0000 | 1,485,900,000 | 1.16% | 0.00% |
| Feb. 19, 2025 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | S | Common Stock | 1510 | $105.35 | 33,129.0000 | 1,485,900,000 | 4.36% | 0.00% |
| Feb. 19, 2025 | Sorenson John Bradley | EVP, Global Operations | S | Common Stock | 3303 | $105.19 | 20,991.0000 | 1,485,900,000 | 13.60% | 0.00% |
| Feb. 18, 2025 | Sorenson John Bradley | EVP, Global Operations | S | Common Stock | 2657 | $104.41 | 24,294.0000 | 1,485,900,000 | 9.86% | 0.00% |
| Feb. 19, 2025 | Brennan Daniel J. | EVP and CFO | M | Stock Option (Right to Buy) | 18533 | $0.00 | 37,067.0000 | 1,485,900,000 | 33.33% | 0.00% |
| Feb. 19, 2025 | Brennan Daniel J. | EVP and CFO | M | Stock Option (Right to Buy) | 16865 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| Feb. 19, 2025 | Brennan Daniel J. | EVP and CFO | M | Stock Option (Right to Buy) | 9483 | $0.00 | 37,934.0000 | 1,485,900,000 | 20.00% | 0.00% |
| Feb. 19, 2025 | Brennan Daniel J. | EVP and CFO | M | Stock Option (Right to Buy) | 15642 | $0.00 | 31,285.0000 | 1,485,900,000 | 33.33% | 0.00% |
| Feb. 19, 2025 | Brennan Daniel J. | EVP and CFO | S | Common Stock | 67333 | $105.24 | 225,808.0000 | 1,485,900,000 | 22.97% | 0.00% |
| Feb. 19, 2025 | Brennan Daniel J. | EVP and CFO | M | Common Stock | 9483 | $40.12 | 293,141.0000 | 1,485,900,000 | 3.34% | 0.00% |
| Feb. 19, 2025 | Brennan Daniel J. | EVP and CFO | M | Common Stock | 15642 | $27.09 | 283,658.0000 | 1,485,900,000 | 5.84% | 0.00% |
| Feb. 19, 2025 | Brennan Daniel J. | EVP and CFO | M | Common Stock | 16865 | $17.26 | 268,016.0000 | 1,485,900,000 | 6.72% | 0.00% |
| Feb. 18, 2025 | Brennan Daniel J. | EVP and CFO | S | Common Stock | 14630 | $104.67 | 232,618.0000 | 1,485,900,000 | 5.92% | 0.00% |
| Feb. 16, 2025 | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 16265 | $0.00 | 1,853,228.0000 | 1,485,900,000 | 0.89% | 0.00% |
| Feb. 16, 2025 | Brennan Daniel J. | EVP and CFO | F | Common Stock | 2052 | $106.11 | 247,781.0000 | 1,485,900,000 | 0.82% | 0.00% |
| Feb. 16, 2025 | Brennan Daniel J. | EVP and CFO | M | Common Stock | 4243 | $0.00 | 249,833.0000 | 1,485,900,000 | 1.73% | 0.00% |
| Feb. 14, 2025 | Brennan Daniel J. | EVP and CFO | F | Common Stock | 2110 | $106.11 | 245,590.0000 | 1,485,900,000 | 0.85% | 0.00% |
| Feb. 14, 2025 | Brennan Daniel J. | EVP and CFO | M | Common Stock | 4362 | $0.00 | 247,700.0000 | 1,485,900,000 | 1.79% | 0.00% |
| Feb. 17, 2025 | Brown Vance R | SVP, GC and Corp. Secretary | M | Restricted Stock Units | 1000 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| Feb. 16, 2025 | Brown Vance R | SVP, GC and Corp. Secretary | M | Restricted Stock Units | 1839 | $0.00 | 1,839.0000 | 1,485,900,000 | 50.00% | 0.00% |
| Feb. 14, 2025 | Brown Vance R | SVP, GC and Corp. Secretary | M | Restricted Stock Units | 1850 | $0.00 | 3,702.0000 | 1,485,900,000 | 33.32% | 0.00% |
| Feb. 13, 2025 | Brown Vance R | SVP, GC and Corp. Secretary | A | Stock Option (Right to Buy) | 11515 | $0.00 | 11,515.0000 | 1,485,900,000 | 9999.99% | 0.00% |
| Feb. 13, 2025 | Brown Vance R | SVP, GC and Corp. Secretary | A | Restricted Stock Units | 4475 | $0.00 | 4,475.0000 | 1,485,900,000 | 9999.99% | 0.00% |
| Feb. 17, 2025 | Brown Vance R | SVP, GC and Corp. Secretary | F | Common Stock | 484 | $106.11 | 50,671.0000 | 1,485,900,000 | 0.95% | 0.00% |
| Feb. 17, 2025 | Brown Vance R | SVP, GC and Corp. Secretary | M | Common Stock | 1000 | $0.00 | 51,155.0000 | 1,485,900,000 | 1.99% | 0.00% |
| Feb. 16, 2025 | Brown Vance R | SVP, GC and Corp. Secretary | F | Common Stock | 890 | $106.11 | 50,155.0000 | 1,485,900,000 | 1.74% | 0.00% |
| Feb. 16, 2025 | Brown Vance R | SVP, GC and Corp. Secretary | M | Common Stock | 1839 | $0.00 | 51,045.0000 | 1,485,900,000 | 3.74% | 0.00% |
| Feb. 14, 2025 | Brown Vance R | SVP, GC and Corp. Secretary | F | Common Stock | 895 | $106.11 | 49,206.0000 | 1,485,900,000 | 1.79% | 0.00% |
| Feb. 14, 2025 | Brown Vance R | SVP, GC and Corp. Secretary | M | Common Stock | 1850 | $0.00 | 50,101.0000 | 1,485,900,000 | 3.83% | 0.00% |
| Feb. 17, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Restricted Stock Units | 2834 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| Feb. 16, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Restricted Stock Units | 2546 | $0.00 | 2,546.0000 | 1,485,900,000 | 50.00% | 0.00% |
| Feb. 14, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Restricted Stock Units | 3172 | $0.00 | 6,346.0000 | 1,485,900,000 | 33.33% | 0.00% |
| Feb. 13, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | A | Stock Option (Right to Buy) | 23031 | $0.00 | 23,031.0000 | 1,485,900,000 | 9999.99% | 0.00% |
| Feb. 13, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | A | Restricted Stock Units | 8950 | $0.00 | 8,950.0000 | 1,485,900,000 | 9999.99% | 0.00% |
| Feb. 17, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | F | Common Stock | 1315 | $106.11 | 35,599.0000 | 1,485,900,000 | 3.56% | 0.00% |
| Feb. 17, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 2834 | $0.00 | 36,914.0000 | 1,485,900,000 | 8.32% | 0.00% |
| Feb. 16, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | F | Common Stock | 1231 | $106.11 | 34,080.0000 | 1,485,900,000 | 3.49% | 0.00% |
| Feb. 16, 2025 | Sorenson John Bradley | EVP, Global Operations | M | Restricted Stock Units | 1273 | $0.00 | 1,273.0000 | 1,485,900,000 | 50.00% | 0.00% |
| Feb. 17, 2025 | Sorenson John Bradley | EVP, Global Operations | M | Restricted Stock Units | 1500 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| Feb. 14, 2025 | O'Sullivan Miriam | SVP, Chief HR Officer | M | Common Stock | 1123 | $0.00 | 15,433.0000 | 1,485,900,000 | 7.85% | 0.00% |
| Feb. 14, 2025 | O'Sullivan Miriam | SVP, Chief HR Officer | F | Common Stock | 330 | $106.11 | 15,103.0000 | 1,485,900,000 | 2.14% | 0.00% |
| Feb. 16, 2025 | O'Sullivan Miriam | SVP, Chief HR Officer | M | Common Stock | 990 | $0.00 | 16,093.0000 | 1,485,900,000 | 6.55% | 0.00% |
| Feb. 16, 2025 | O'Sullivan Miriam | SVP, Chief HR Officer | F | Common Stock | 291 | $106.11 | 15,802.0000 | 1,485,900,000 | 1.81% | 0.00% |
| Feb. 17, 2025 | O'Sullivan Miriam | SVP, Chief HR Officer | M | Common Stock | 1000 | $0.00 | 16,802.0000 | 1,485,900,000 | 6.33% | 0.00% |
| Feb. 17, 2025 | O'Sullivan Miriam | SVP, Chief HR Officer | F | Common Stock | 294 | $106.11 | 16,508.0000 | 1,485,900,000 | 1.75% | 0.00% |
| Feb. 14, 2025 | O'Sullivan Miriam | SVP, Chief HR Officer | M | Common Stock | 106 | $0.00 | 16,427.0000 | 1,485,900,000 | 0.65% | 0.00% |
| Feb. 14, 2025 | O'Sullivan Miriam | SVP, Chief HR Officer | F | Common Stock | 38 | $106.11 | 16,389.0000 | 1,485,900,000 | 0.23% | 0.00% |
| Feb. 16, 2025 | O'Sullivan Miriam | SVP, Chief HR Officer | M | Common Stock | 85 | $0.00 | 16,474.0000 | 1,485,900,000 | 0.52% | 0.00% |
| Feb. 16, 2025 | O'Sullivan Miriam | SVP, Chief HR Officer | F | Common Stock | 30 | $106.11 | 16,444.0000 | 1,485,900,000 | 0.18% | 0.00% |
| Feb. 17, 2025 | O'Sullivan Miriam | SVP, Chief HR Officer | M | Common Stock | 100 | $0.00 | 16,544.0000 | 1,485,900,000 | 0.61% | 0.00% |
| Feb. 17, 2025 | O'Sullivan Miriam | SVP, Chief HR Officer | F | Common Stock | 36 | $106.11 | 16,508.0000 | 1,485,900,000 | 0.22% | 0.00% |
| Feb. 13, 2025 | O'Sullivan Miriam | SVP, Chief HR Officer | A | Restricted Stock Units | 2355 | $0.00 | 2,355.0000 | 1,485,900,000 | 9999.99% | 0.00% |
| Feb. 13, 2025 | O'Sullivan Miriam | SVP, Chief HR Officer | A | Stock Option (Right to Buy) | 6061 | $0.00 | 6,061.0000 | 1,485,900,000 | 9999.99% | 0.00% |
| Feb. 14, 2025 | O'Sullivan Miriam | SVP, Chief HR Officer | M | Restricted Stock Units | 1123 | $0.00 | 2,248.0000 | 1,485,900,000 | 33.31% | 0.00% |
| Feb. 16, 2025 | O'Sullivan Miriam | SVP, Chief HR Officer | M | Restricted Stock Units | 990 | $0.00 | 990.0000 | 1,485,900,000 | 50.00% | 0.00% |
| Feb. 17, 2025 | O'Sullivan Miriam | SVP, Chief HR Officer | M | Restricted Stock Units | 1000 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| Feb. 13, 2025 | O'Sullivan Miriam | SVP, Chief HR Officer | A | Restricted Stock Units | 188 | $0.00 | 188.0000 | 1,485,900,000 | 9999.99% | 0.00% |
| Feb. 14, 2025 | O'Sullivan Miriam | SVP, Chief HR Officer | M | Restricted Stock Units | 106 | $0.00 | 212.0000 | 1,485,900,000 | 33.33% | 0.00% |
| Feb. 16, 2025 | O'Sullivan Miriam | SVP, Chief HR Officer | M | Restricted Stock Units | 85 | $0.00 | 85.0000 | 1,485,900,000 | 50.00% | 0.00% |
| Feb. 17, 2025 | O'Sullivan Miriam | SVP, Chief HR Officer | M | Restricted Stock Units | 100 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| Feb. 14, 2025 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Common Stock | 2776 | $0.00 | 32,477.0000 | 1,485,900,000 | 9.35% | 0.00% |
| Feb. 14, 2025 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | F | Common Stock | 1266 | $106.11 | 31,211.0000 | 1,485,900,000 | 3.90% | 0.00% |
| Feb. 16, 2025 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Common Stock | 2970 | $0.00 | 34,181.0000 | 1,485,900,000 | 9.52% | 0.00% |
| Feb. 16, 2025 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | F | Common Stock | 1355 | $106.11 | 32,826.0000 | 1,485,900,000 | 3.96% | 0.00% |
| Feb. 17, 2025 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Common Stock | 3334 | $0.00 | 36,160.0000 | 1,485,900,000 | 10.16% | 0.00% |
| Feb. 17, 2025 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | F | Common Stock | 1521 | $106.11 | 34,639.0000 | 1,485,900,000 | 4.21% | 0.00% |
| Feb. 13, 2025 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | A | Restricted Stock Units | 5181 | $0.00 | 5,181.0000 | 1,485,900,000 | 9999.99% | 0.00% |
| Feb. 13, 2025 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | A | Stock Option (Right to Buy) | 13334 | $0.00 | 13,334.0000 | 1,485,900,000 | 9999.99% | 0.00% |
| Feb. 14, 2025 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Restricted Stock Units | 2776 | $0.00 | 5,552.0000 | 1,485,900,000 | 33.33% | 0.00% |
| Feb. 16, 2025 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Restricted Stock Units | 2970 | $0.00 | 2,970.0000 | 1,485,900,000 | 50.00% | 0.00% |
| Feb. 17, 2025 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Restricted Stock Units | 3334 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| Feb. 14, 2025 | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 16524 | $0.00 | 1,844,953.0000 | 1,485,900,000 | 0.90% | 0.00% |
| Feb. 14, 2025 | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 7990 | $106.11 | 1,836,963.0000 | 1,485,900,000 | 0.43% | 0.00% |
| Feb. 17, 2025 | Brennan Daniel J. | EVP and CFO | M | Common Stock | 4584 | $0.00 | 252,365.0000 | 1,485,900,000 | 1.85% | 0.00% |
| Feb. 16, 2025 | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 7865 | $106.11 | 1,845,363.0000 | 1,485,900,000 | 0.42% | 0.00% |
| Feb. 17, 2025 | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 18334 | $0.00 | 1,863,697.0000 | 1,485,900,000 | 0.99% | 0.00% |
| Feb. 17, 2025 | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 8865 | $106.11 | 1,854,832.0000 | 1,485,900,000 | 0.48% | 0.00% |
| Feb. 13, 2025 | Mahoney Michael F | Chairman, President & CEO | A | Restricted Stock Units | 35330 | $0.00 | 35,330.0000 | 1,485,900,000 | 9999.99% | 0.00% |
| Feb. 13, 2025 | Mahoney Michael F | Chairman, President & CEO | A | Stock Option (Right to Buy) | 90915 | $0.00 | 90,915.0000 | 1,485,900,000 | 9999.99% | 0.01% |
| Feb. 14, 2025 | Mahoney Michael F | Chairman, President & CEO | M | Restricted Stock Units | 16524 | $0.00 | 33,048.0000 | 1,485,900,000 | 33.33% | 0.00% |
| Feb. 16, 2025 | Mahoney Michael F | Chairman, President & CEO | M | Restricted Stock Units | 16265 | $0.00 | 16,265.0000 | 1,485,900,000 | 50.00% | 0.00% |
| Feb. 17, 2025 | Mahoney Michael F | Chairman, President & CEO | M | Restricted Stock Units | 18334 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| Feb. 14, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 4362 | $0.00 | 184,002.0000 | 1,485,900,000 | 2.43% | 0.00% |
| Feb. 14, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 1990 | $106.11 | 182,012.0000 | 1,485,900,000 | 1.08% | 0.00% |
| Feb. 16, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 3960 | $0.00 | 185,972.0000 | 1,485,900,000 | 2.18% | 0.00% |
| Feb. 16, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 1806 | $106.11 | 184,166.0000 | 1,485,900,000 | 0.97% | 0.00% |
| Feb. 17, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 4167 | $0.00 | 188,333.0000 | 1,485,900,000 | 2.26% | 0.00% |
| Feb. 17, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 2057 | $106.11 | 186,276.0000 | 1,485,900,000 | 1.09% | 0.00% |
| Feb. 13, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | A | Restricted Stock Units | 11188 | $0.00 | 11,188.0000 | 1,485,900,000 | 9999.99% | 0.00% |
| Feb. 13, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | A | Stock Option (Right to Buy) | 28789 | $0.00 | 28,789.0000 | 1,485,900,000 | 9999.99% | 0.00% |
| Feb. 14, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Restricted Stock Units | 4362 | $0.00 | 8,725.0000 | 1,485,900,000 | 33.33% | 0.00% |
| Feb. 16, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Restricted Stock Units | 3960 | $0.00 | 3,960.0000 | 1,485,900,000 | 50.00% | 0.00% |
| Feb. 17, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Restricted Stock Units | 4167 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| Feb. 14, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 3172 | $0.00 | 34,299.0000 | 1,485,900,000 | 10.19% | 0.00% |
| Feb. 14, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | F | Common Stock | 1534 | $106.11 | 32,765.0000 | 1,485,900,000 | 4.47% | 0.00% |
| Feb. 16, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 2546 | $0.00 | 35,311.0000 | 1,485,900,000 | 7.77% | 0.00% |
| Feb. 17, 2025 | Brennan Daniel J. | EVP and CFO | M | Restricted Stock Units | 4584 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| Feb. 16, 2025 | Brennan Daniel J. | EVP and CFO | M | Restricted Stock Units | 4243 | $0.00 | 4,243.0000 | 1,485,900,000 | 50.00% | 0.00% |
| Feb. 14, 2025 | Brennan Daniel J. | EVP and CFO | M | Restricted Stock Units | 4362 | $0.00 | 8,725.0000 | 1,485,900,000 | 33.33% | 0.00% |
| Feb. 13, 2025 | Brennan Daniel J. | EVP and CFO | A | Stock Option (Right to Buy) | 23031 | $0.00 | 23,031.0000 | 1,485,900,000 | 9999.99% | 0.00% |
| Feb. 13, 2025 | Brennan Daniel J. | EVP and CFO | A | Restricted Stock Units | 8950 | $0.00 | 8,950.0000 | 1,485,900,000 | 9999.99% | 0.00% |
| Feb. 17, 2025 | Brennan Daniel J. | EVP and CFO | F | Common Stock | 2217 | $106.11 | 250,148.0000 | 1,485,900,000 | 0.88% | 0.00% |
| Feb. 14, 2025 | Woodworth Emily | SVP, Global Controller and CAO | M | Common Stock | 661 | $0.00 | 3,867.0000 | 1,485,900,000 | 20.62% | 0.00% |
| Feb. 14, 2025 | Woodworth Emily | SVP, Global Controller and CAO | F | Common Stock | 315 | $106.11 | 3,552.0000 | 1,485,900,000 | 8.15% | 0.00% |
| Feb. 16, 2025 | Woodworth Emily | SVP, Global Controller and CAO | M | Common Stock | 636 | $0.00 | 4,188.0000 | 1,485,900,000 | 17.91% | 0.00% |
| Feb. 16, 2025 | Woodworth Emily | SVP, Global Controller and CAO | F | Common Stock | 271 | $106.11 | 3,917.0000 | 1,485,900,000 | 6.47% | 0.00% |
| Feb. 17, 2025 | Woodworth Emily | SVP, Global Controller and CAO | M | Common Stock | 667 | $0.00 | 4,584.0000 | 1,485,900,000 | 17.03% | 0.00% |
| Feb. 17, 2025 | Woodworth Emily | SVP, Global Controller and CAO | F | Common Stock | 283 | $106.11 | 4,301.0000 | 1,485,900,000 | 6.17% | 0.00% |
| Feb. 13, 2025 | Woodworth Emily | SVP, Global Controller and CAO | A | Restricted Stock Units | 5652 | $0.00 | 5,652.0000 | 1,485,900,000 | 9999.99% | 0.00% |
| Feb. 13, 2025 | Woodworth Emily | SVP, Global Controller and CAO | A | Stock Option (Right to Buy) | 5732 | $0.00 | 5,732.0000 | 1,485,900,000 | 9999.99% | 0.00% |
| Feb. 14, 2025 | Woodworth Emily | SVP, Global Controller and CAO | M | Restricted Stock Units | 661 | $0.00 | 1,322.0000 | 1,485,900,000 | 33.33% | 0.00% |
| Feb. 16, 2025 | Woodworth Emily | SVP, Global Controller and CAO | M | Restricted Stock Units | 636 | $0.00 | 637.0000 | 1,485,900,000 | 49.96% | 0.00% |
| Feb. 17, 2025 | Woodworth Emily | SVP, Global Controller and CAO | M | Restricted Stock Units | 667 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| Feb. 14, 2025 | Sorenson John Bradley | EVP, Global Operations | M | Common Stock | 2115 | $0.00 | 27,609.0000 | 1,485,900,000 | 8.30% | 0.00% |
| Feb. 14, 2025 | Sorenson John Bradley | EVP, Global Operations | F | Common Stock | 965 | $106.11 | 26,644.0000 | 1,485,900,000 | 3.50% | 0.00% |
| Feb. 14, 2025 | Sorenson John Bradley | EVP, Global Operations | S | Common Stock | 1201 | $106.31 | 25,443.0000 | 1,485,900,000 | 4.51% | 0.00% |
| Feb. 16, 2025 | Sorenson John Bradley | EVP, Global Operations | M | Common Stock | 1273 | $0.00 | 26,716.0000 | 1,485,900,000 | 5.00% | 0.00% |
| Feb. 16, 2025 | Sorenson John Bradley | EVP, Global Operations | F | Common Stock | 581 | $106.11 | 26,135.0000 | 1,485,900,000 | 2.17% | 0.00% |
| Feb. 17, 2025 | Sorenson John Bradley | EVP, Global Operations | M | Common Stock | 1500 | $0.00 | 27,635.0000 | 1,485,900,000 | 5.74% | 0.00% |
| Feb. 17, 2025 | Sorenson John Bradley | EVP, Global Operations | F | Common Stock | 684 | $106.11 | 26,951.0000 | 1,485,900,000 | 2.48% | 0.00% |
| Feb. 13, 2025 | Sorenson John Bradley | EVP, Global Operations | A | Restricted Stock Units | 4239 | $0.00 | 4,239.0000 | 1,485,900,000 | 9999.99% | 0.00% |
| Feb. 13, 2025 | Sorenson John Bradley | EVP, Global Operations | A | Stock Option (Right to Buy) | 10909 | $0.00 | 10,909.0000 | 1,485,900,000 | 9999.99% | 0.00% |
| Feb. 14, 2025 | Sorenson John Bradley | EVP, Global Operations | M | Restricted Stock Units | 2115 | $0.00 | 4,230.0000 | 1,485,900,000 | 33.33% | 0.00% |
| Feb. 12, 2025 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Restricted Stock Units | 2115 | $0.00 | 6,347.0000 | 1,485,900,000 | 24.99% | 0.00% |
| Feb. 12, 2025 | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 13704 | $0.00 | 1,835,055.0000 | 1,485,900,000 | 0.75% | 0.00% |
| Feb. 12, 2025 | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 6626 | $105.77 | 1,828,429.0000 | 1,485,900,000 | 0.36% | 0.00% |
| Feb. 12, 2025 | Mahoney Michael F | Chairman, President & CEO | M | Restricted Stock Units | 13704 | $0.00 | 41,112.0000 | 1,485,900,000 | 25.00% | 0.00% |
| Feb. 12, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 3462 | $0.00 | 181,219.0000 | 1,485,900,000 | 1.95% | 0.00% |
| Feb. 12, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 1579 | $105.77 | 179,640.0000 | 1,485,900,000 | 0.87% | 0.00% |
| Feb. 12, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Restricted Stock Units | 3462 | $0.00 | 10,386.0000 | 1,485,900,000 | 25.00% | 0.00% |
| Feb. 12, 2025 | Brennan Daniel J. | EVP and CFO | M | Restricted Stock Units | 3654 | $0.00 | 10,963.0000 | 1,485,900,000 | 25.00% | 0.00% |
| Feb. 12, 2025 | Brennan Daniel J. | EVP and CFO | F | Common Stock | 1767 | $105.77 | 243,338.0000 | 1,485,900,000 | 0.72% | 0.00% |
| Feb. 12, 2025 | Brennan Daniel J. | EVP and CFO | M | Common Stock | 3654 | $0.00 | 245,105.0000 | 1,485,900,000 | 1.51% | 0.00% |
| Feb. 12, 2025 | Brown Vance R | SVP, GC and Corp. Secretary | M | Common Stock | 1442 | $0.00 | 48,675.0000 | 1,485,900,000 | 3.05% | 0.00% |
| Feb. 12, 2025 | O'Sullivan Miriam | SVP, Chief HR Officer | F | Common Stock | 338 | $105.77 | 14,123.0000 | 1,485,900,000 | 2.34% | 0.00% |
| Feb. 12, 2025 | O'Sullivan Miriam | SVP, Chief HR Officer | M | Common Stock | 961 | $0.00 | 14,461.0000 | 1,485,900,000 | 7.12% | 0.00% |
| Feb. 12, 2025 | Sorenson John Bradley | EVP, Global Operations | M | Restricted Stock Units | 1731 | $0.00 | 5,193.0000 | 1,485,900,000 | 25.00% | 0.00% |
| Feb. 12, 2025 | Sorenson John Bradley | EVP, Global Operations | F | Common Stock | 530 | $105.77 | 25,494.0000 | 1,485,900,000 | 2.04% | 0.00% |
| Feb. 12, 2025 | Sorenson John Bradley | EVP, Global Operations | M | Common Stock | 1731 | $0.00 | 26,024.0000 | 1,485,900,000 | 7.13% | 0.00% |
| Feb. 12, 2025 | Woodworth Emily | SVP, Global Controller and CAO | M | Restricted Stock Units | 480 | $0.00 | 1,443.0000 | 1,485,900,000 | 24.96% | 0.00% |
| Feb. 12, 2025 | Woodworth Emily | SVP, Global Controller and CAO | F | Common Stock | 231 | $105.77 | 3,206.0000 | 1,485,900,000 | 6.72% | 0.00% |
| Feb. 12, 2025 | Woodworth Emily | SVP, Global Controller and CAO | M | Common Stock | 480 | $0.00 | 3,437.0000 | 1,485,900,000 | 16.23% | 0.00% |
| Feb. 12, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Restricted Stock Units | 2692 | $0.00 | 8,078.0000 | 1,485,900,000 | 25.00% | 0.00% |
| Feb. 12, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | F | Common Stock | 950 | $105.77 | 31,127.0000 | 1,485,900,000 | 2.96% | 0.00% |
| Feb. 12, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 2692 | $0.00 | 32,077.0000 | 1,485,900,000 | 9.16% | 0.00% |
| Feb. 12, 2025 | Brown Vance R | SVP, GC and Corp. Secretary | M | Restricted Stock Units | 1442 | $0.00 | 4,328.0000 | 1,485,900,000 | 24.99% | 0.00% |
| Feb. 12, 2025 | Brown Vance R | SVP, GC and Corp. Secretary | F | Common Stock | 424 | $105.77 | 48,251.0000 | 1,485,900,000 | 0.87% | 0.00% |
| Feb. 12, 2025 | O'Sullivan Miriam | SVP, Chief HR Officer | M | Common Stock | 65 | $0.00 | 14,146.0000 | 1,485,900,000 | 0.46% | 0.00% |
| Feb. 12, 2025 | O'Sullivan Miriam | SVP, Chief HR Officer | F | Common Stock | 23 | $105.77 | 14,123.0000 | 1,485,900,000 | 0.16% | 0.00% |
| Feb. 12, 2025 | O'Sullivan Miriam | SVP, Chief HR Officer | M | Restricted Stock Units | 961 | $0.00 | 3,081.0000 | 1,485,900,000 | 23.78% | 0.00% |
| Feb. 12, 2025 | O'Sullivan Miriam | SVP, Chief HR Officer | M | Restricted Stock Units | 65 | $0.00 | 3,081.0000 | 1,485,900,000 | 2.07% | 0.00% |
| Feb. 12, 2025 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Common Stock | 2115 | $0.00 | 30,569.0000 | 1,485,900,000 | 7.43% | 0.00% |
| Feb. 12, 2025 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | F | Common Stock | 868 | $105.77 | 29,701.0000 | 1,485,900,000 | 2.84% | 0.00% |
| Feb. 11, 2025 | Sorenson John Bradley | EVP, Global Operations | F | Common Stock | 3793 | $105.98 | 32,838.0000 | 1,485,900,000 | 10.35% | 0.00% |
| Feb. 11, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | A | Common Stock | 31680 | $0.00 | 192,204.0000 | 1,485,900,000 | 19.74% | 0.00% |
| Feb. 11, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 14447 | $105.98 | 177,757.0000 | 1,485,900,000 | 7.52% | 0.00% |
| Feb. 11, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | A | Common Stock | 20366 | $0.00 | 39,232.0000 | 1,485,900,000 | 107.95% | 0.00% |
| Feb. 11, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | F | Common Stock | 9847 | $105.98 | 29,385.0000 | 1,485,900,000 | 25.10% | 0.00% |
| Feb. 11, 2025 | Brown Vance R | SVP, GC and Corp. Secretary | A | Common Stock | 14708 | $0.00 | 53,583.0000 | 1,485,900,000 | 37.83% | 0.00% |
| Feb. 11, 2025 | Brown Vance R | SVP, GC and Corp. Secretary | F | Common Stock | 6350 | $105.98 | 47,233.0000 | 1,485,900,000 | 11.85% | 0.00% |
| Feb. 11, 2025 | Brennan Daniel J. | EVP and CFO | A | Common Stock | 33944 | $0.00 | 257,865.0000 | 1,485,900,000 | 15.16% | 0.00% |
| Dec. 3, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | P | Common Stock | 50 | $90.29 | 153,062.0000 | 1,487,400,000 | 0.03% | 0.00% |
| Feb. 11, 2025 | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 62915 | $105.98 | 1,821,351.0000 | 1,485,900,000 | 3.34% | 0.00% |
| Feb. 11, 2025 | Mahoney Michael F | Chairman, President & CEO | A | Common Stock | 130118 | $0.00 | 1,884,266.0000 | 1,485,900,000 | 7.42% | 0.01% |
| Feb. 12, 2025 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | S | Common Stock | 13022 | $105.06 | 28,454.0000 | 1,485,900,000 | 31.40% | 0.00% |
| Feb. 11, 2025 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | F | Common Stock | 10738 | $105.98 | 41,476.0000 | 1,485,900,000 | 20.57% | 0.00% |
| Feb. 11, 2025 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | A | Common Stock | 23760 | $0.00 | 52,214.0000 | 1,485,900,000 | 83.50% | 0.00% |
| Feb. 12, 2025 | Sorenson John Bradley | EVP, Global Operations | S | Common Stock | 6389 | $105.06 | 24,293.0000 | 1,485,900,000 | 20.82% | 0.00% |
| Feb. 12, 2025 | Sorenson John Bradley | EVP, Global Operations | G | Common Stock | 2156 | $0.00 | 30,682.0000 | 1,485,900,000 | 6.57% | 0.00% |
| Dec. 10, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | S | Common Stock | 20 | $89.97 | 153,042.0000 | 1,487,400,000 | 0.01% | 0.00% |
| Feb. 11, 2025 | Sorenson John Bradley | EVP, Global Operations | A | Common Stock | 10182 | $0.00 | 36,631.0000 | 1,485,900,000 | 38.50% | 0.00% |
| Feb. 12, 2025 | Brennan Daniel J. | EVP and CFO | M | Stock Option (Right to Buy) | 15087 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| Feb. 12, 2025 | Brennan Daniel J. | EVP and CFO | S | Common Stock | 15087 | $105.07 | 241,451.0000 | 1,485,900,000 | 5.88% | 0.00% |
| Feb. 12, 2025 | Brennan Daniel J. | EVP and CFO | M | Common Stock | 15087 | $16.31 | 256,538.0000 | 1,485,900,000 | 6.25% | 0.00% |
| Feb. 11, 2025 | Brennan Daniel J. | EVP and CFO | F | Common Stock | 16414 | $105.98 | 241,451.0000 | 1,485,900,000 | 6.37% | 0.00% |
| Feb. 11, 2025 | LUDWIG EDWARD J | Director | G | Common Stock | 3000 | $0.00 | 36,398.0000 | 1,485,900,000 | 7.61% | 0.00% |
| Feb. 11, 2025 | LUDWIG EDWARD J | Director | S | Common Stock | 12000 | $105.48 | 24,398.0000 | 1,485,900,000 | 32.97% | 0.00% |
| Feb. 7, 2025 | Sorenson John Bradley | EVP, Global Operations | S | Common Stock | 6528 | $104.97 | 26,449.0000 | 1,485,900,000 | 19.80% | 0.00% |
| Feb. 3, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 6952 | $27.09 | 25,818.0000 | 1,485,900,000 | 36.85% | 0.00% |
| Feb. 3, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 6176 | $24.55 | 31,994.0000 | 1,485,900,000 | 23.92% | 0.00% |
| Feb. 3, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 3176 | $22.71 | 35,170.0000 | 1,485,900,000 | 9.93% | 0.00% |
| Feb. 3, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 1009 | $17.26 | 36,179.0000 | 1,485,900,000 | 2.87% | 0.00% |
| Feb. 3, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | S | Common Stock | 8508 | $101.45 | 27,671.0000 | 1,485,900,000 | 23.52% | 0.00% |
| Feb. 3, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | S | Common Stock | 8805 | $102.14 | 18,866.0000 | 1,485,900,000 | 31.82% | 0.00% |
| Feb. 3, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Stock Option (Right to Buy) | 6952 | $0.00 | 20,856.0000 | 1,485,900,000 | 25.00% | 0.00% |
| Feb. 3, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Stock Option (Right to Buy) | 1009 | $0.00 | 3,027.0000 | 1,485,900,000 | 25.00% | 0.00% |
| Feb. 3, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Stock Option (Right to Buy) | 6176 | $0.00 | 18,527.0000 | 1,485,900,000 | 25.00% | 0.00% |
| Feb. 3, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Stock Option (Right to Buy) | 3176 | $0.00 | 9,530.0000 | 1,485,900,000 | 25.00% | 0.00% |
| Jan. 2, 2025 | Sorenson John Bradley | EVP, Global Operations | S | Common Stock | 4119 | $90.02 | 35,319.0000 | 1,485,900,000 | 10.44% | 0.00% |
| Jan. 1, 2025 | Sorenson John Bradley | EVP, Global Operations | M | Common Stock | 4469 | $0.00 | 41,565.0000 | 1,485,900,000 | 12.05% | 0.00% |
| Jan. 1, 2025 | Sorenson John Bradley | EVP, Global Operations | F | Common Stock | 2127 | $89.32 | 39,438.0000 | 1,485,900,000 | 5.12% | 0.00% |
| Jan. 3, 2025 | Sorenson John Bradley | EVP, Global Operations | S | Common Stock | 2342 | $89.86 | 32,977.0000 | 1,485,900,000 | 6.63% | 0.00% |
| Jan. 1, 2025 | Sorenson John Bradley | EVP, Global Operations | M | Performance Share Units | 4469 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| Jan. 1, 2025 | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 57121 | $0.00 | 1,779,804.0000 | 1,485,900,000 | 3.32% | 0.00% |
| Jan. 1, 2025 | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 25656 | $89.32 | 1,754,148.0000 | 1,485,900,000 | 1.44% | 0.00% |
| Jan. 1, 2025 | Mahoney Michael F | Chairman, President & CEO | M | Performance Share Units | 57121 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| Jan. 1, 2025 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Common Stock | 10430 | $0.00 | 38,884.0000 | 1,485,900,000 | 36.66% | 0.00% |
| Jan. 1, 2025 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | F | Common Stock | 3278 | $89.32 | 35,606.0000 | 1,485,900,000 | 8.43% | 0.00% |
| Jan. 3, 2025 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | S | Common Stock | 7152 | $89.86 | 28,454.0000 | 1,485,900,000 | 20.09% | 0.00% |
| Jan. 1, 2025 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Performance Share Units | 10430 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| Jan. 1, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 13907 | $0.00 | 166,919.0000 | 1,485,900,000 | 9.09% | 0.00% |
| Jan. 1, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 6425 | $89.32 | 160,494.0000 | 1,485,900,000 | 3.85% | 0.00% |
| Jan. 1, 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Performance Share Units | 13907 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| Jan. 1, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 8940 | $0.00 | 23,285.0000 | 1,485,900,000 | 62.32% | 0.00% |
| Jan. 1, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | F | Common Stock | 4416 | $89.32 | 18,869.0000 | 1,485,900,000 | 18.97% | 0.00% |
| Jan. 1, 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Performance Share Units | 8940 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| Jan. 1, 2025 | Brown Vance R | SVP, GC and Corp. Secretary | M | Common Stock | 6456 | $0.00 | 40,866.0000 | 1,485,900,000 | 18.76% | 0.00% |
| Jan. 1, 2025 | Brown Vance R | SVP, GC and Corp. Secretary | F | Common Stock | 1991 | $89.32 | 38,875.0000 | 1,485,900,000 | 4.87% | 0.00% |
| Jan. 1, 2025 | Brown Vance R | SVP, GC and Corp. Secretary | M | Performance Share Units | 6456 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| Jan. 1, 2025 | Brennan Daniel J. | EVP and CFO | M | Common Stock | 14901 | $0.00 | 238,822.0000 | 1,485,900,000 | 6.65% | 0.00% |
| Jan. 1, 2025 | Brennan Daniel J. | EVP and CFO | F | Common Stock | 5212 | $89.32 | 233,610.0000 | 1,485,900,000 | 2.18% | 0.00% |
| Jan. 3, 2025 | Brennan Daniel J. | EVP and CFO | S | Common Stock | 9689 | $89.86 | 223,921.0000 | 1,485,900,000 | 4.15% | 0.00% |
| Jan. 1, 2025 | Brennan Daniel J. | EVP and CFO | M | Performance Share Units | 14901 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| Dec. 2, 2024 | Carruthers Wendy | EVP, Human Resources | M | Common Stock | 3066 | $17.26 | 35,094.0000 | 1,487,400,000 | 9.57% | 0.00% |
| Dec. 2, 2024 | Carruthers Wendy | EVP, Human Resources | M | Common Stock | 1197 | $24.55 | 36,291.0000 | 1,487,400,000 | 3.41% | 0.00% |
| Dec. 2, 2024 | Carruthers Wendy | EVP, Human Resources | S | Common Stock | 6983 | $90.78 | 29,308.0000 | 1,487,400,000 | 19.24% | 0.00% |
| Dec. 2, 2024 | Carruthers Wendy | EVP, Human Resources | M | Stock Option (Right to Buy) | 3066 | $0.00 | 0.0000 | 1,487,400,000 | 100.00% | 0.00% |
| Dec. 2, 2024 | Carruthers Wendy | EVP, Human Resources | M | Stock Option (Right to Buy) | 1197 | $0.00 | 13,183.0000 | 1,487,400,000 | 8.32% | 0.00% |
| Nov. 27, 2024 | Woodworth Emily | SVP, Global Controller and CAO | S | Common Stock | 1336 | $90.65 | 2,957.0000 | 1,487,400,000 | 31.12% | 0.00% |
| Nov. 26, 2024 | Mahoney Michael F | Chairman, President & CEO | G | Common Stock | 7800 | $0.00 | 1,722,683.0000 | 1,487,400,000 | 0.45% | 0.00% |
| Nov. 25, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | G | Common Stock | 1113 | $0.00 | 164,248.0000 | 1,487,400,000 | 0.67% | 0.00% |
| Nov. 26, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | G | Common Stock | 11236 | $0.00 | 153,012.0000 | 1,487,400,000 | 6.84% | 0.00% |
| Nov. 25, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 3177 | $22.71 | 27,352.0000 | 1,487,400,000 | 13.14% | 0.00% |
| Nov. 25, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 1009 | $17.26 | 28,361.0000 | 1,487,400,000 | 3.69% | 0.00% |
| Nov. 25, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | S | Common Stock | 14010 | $89.27 | 14,351.0000 | 1,487,400,000 | 49.40% | 0.00% |
| Nov. 25, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Stock Option (Right to Buy) | 1009 | $0.00 | 4,036.0000 | 1,487,400,000 | 20.00% | 0.00% |
| Nov. 25, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Stock Option (Right to Buy) | 3177 | $0.00 | 12,706.0000 | 1,487,400,000 | 20.00% | 0.00% |
| Nov. 21, 2024 | LUDWIG EDWARD J | Director | S | Common Stock | 4877 | $91.63 | 39,398.0000 | 1,487,400,000 | 11.02% | 0.00% |
| Nov. 12, 2024 | Sorenson John Bradley | EVP, Global Operations | G | Common Stock | 2610 | $0.00 | 37,096.0000 | 1,487,400,000 | 6.57% | 0.00% |
| Nov. 8, 2024 | Sorenson John Bradley | EVP, Global Operations | S | Common Stock | 30580 | $87.66 | 39,706.0000 | 1,487,400,000 | 43.51% | 0.00% |
| Nov. 8, 2024 | Sorenson John Bradley | EVP, Global Operations | M | Common Stock | 17362 | $24.55 | 70,286.0000 | 1,487,400,000 | 32.81% | 0.00% |
| Nov. 8, 2024 | Sorenson John Bradley | EVP, Global Operations | M | Stock Option (Right to Buy) | 17362 | $0.00 | 0.0000 | 1,487,400,000 | 100.00% | 0.00% |
| Nov. 5, 2024 | Mahoney Michael F | Chairman, President & CEO | M | Stock Option (Right to Buy) | 55676 | $0.00 | 0.0000 | 1,487,400,000 | 100.00% | 0.00% |
| Nov. 5, 2024 | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 56211 | $17.26 | 1,837,585.0000 | 1,487,400,000 | 3.16% | 0.00% |
| Nov. 5, 2024 | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 55676 | $16.31 | 1,893,261.0000 | 1,487,400,000 | 3.03% | 0.00% |
| Nov. 5, 2024 | Mahoney Michael F | Chairman, President & CEO | S | Common Stock | 2596 | $85.17 | 1,890,665.0000 | 1,487,400,000 | 0.14% | 0.00% |
| Nov. 5, 2024 | Mahoney Michael F | Chairman, President & CEO | S | Common Stock | 160182 | $84.74 | 1,730,483.0000 | 1,487,400,000 | 8.47% | 0.01% |
| Nov. 5, 2024 | Mahoney Michael F | Chairman, President & CEO | M | Stock Option (Right to Buy) | 56211 | $0.00 | 168,635.0000 | 1,487,400,000 | 25.00% | 0.00% |
| Nov. 1, 2024 | Carruthers Wendy | EVP, Human Resources | M | Common Stock | 3066 | $17.26 | 37,814.0000 | 1,487,400,000 | 8.82% | 0.00% |
| Nov. 1, 2024 | Carruthers Wendy | EVP, Human Resources | M | Common Stock | 1197 | $24.55 | 39,011.0000 | 1,487,400,000 | 3.17% | 0.00% |
| Nov. 1, 2024 | Carruthers Wendy | EVP, Human Resources | S | Common Stock | 6983 | $84.33 | 32,028.0000 | 1,487,400,000 | 17.90% | 0.00% |
| Nov. 1, 2024 | Carruthers Wendy | EVP, Human Resources | M | Stock Option (Right to Buy) | 3066 | $0.00 | 3,066.0000 | 1,487,400,000 | 50.00% | 0.00% |
| Nov. 1, 2024 | Carruthers Wendy | EVP, Human Resources | M | Stock Option (Right to Buy) | 1197 | $0.00 | 14,380.0000 | 1,487,400,000 | 7.68% | 0.00% |
| Oct. 7, 2024 | Mahoney Michael F | Chairman, President & CEO | M | Stock Option (Right to Buy) | 56211 | $0.00 | 224,846.0000 | 1,487,400,000 | 20.00% | 0.00% |
| Oct. 7, 2024 | Mahoney Michael F | Chairman, President & CEO | M | Stock Option (Right to Buy) | 55675 | $0.00 | 55,676.0000 | 1,487,400,000 | 50.00% | 0.00% |
| Oct. 7, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 59021 | $17.26 | 240,270.0000 | 1,487,400,000 | 32.56% | 0.00% |
| Oct. 7, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 57618 | $24.98 | 297,888.0000 | 1,487,400,000 | 23.98% | 0.00% |
| Oct. 7, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | S | Common Stock | 132527 | $85.00 | 165,361.0000 | 1,487,400,000 | 44.49% | 0.01% |
| Oct. 7, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Stock Option (Right to Buy) | 57618 | $0.00 | 0.0000 | 1,487,400,000 | 100.00% | 0.00% |
| Oct. 7, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Stock Option (Right to Buy) | 59021 | $0.00 | 0.0000 | 1,487,400,000 | 100.00% | 0.00% |
| Oct. 7, 2024 | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 56211 | $17.26 | 1,888,476.0000 | 1,487,400,000 | 3.07% | 0.00% |
| Oct. 7, 2024 | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 55675 | $16.31 | 1,944,151.0000 | 1,487,400,000 | 2.95% | 0.00% |
| Oct. 7, 2024 | Mahoney Michael F | Chairman, President & CEO | S | Common Stock | 80692 | $84.31 | 1,863,459.0000 | 1,487,400,000 | 4.15% | 0.01% |
| Oct. 7, 2024 | Mahoney Michael F | Chairman, President & CEO | S | Common Stock | 82085 | $84.94 | 1,781,374.0000 | 1,487,400,000 | 4.40% | 0.01% |
| Oct. 1, 2024 | Carruthers Wendy | EVP, Human Resources | M | Stock Option (Right to Buy) | 3066 | $0.00 | 6,132.0000 | 1,487,400,000 | 33.33% | 0.00% |
| Oct. 1, 2024 | Carruthers Wendy | EVP, Human Resources | M | Common Stock | 3066 | $17.26 | 40,534.0000 | 1,487,400,000 | 8.18% | 0.00% |
| Oct. 1, 2024 | Carruthers Wendy | EVP, Human Resources | M | Common Stock | 1197 | $24.55 | 41,731.0000 | 1,487,400,000 | 2.95% | 0.00% |
| Oct. 1, 2024 | Carruthers Wendy | EVP, Human Resources | S | Common Stock | 6983 | $83.86 | 34,748.0000 | 1,487,400,000 | 16.73% | 0.00% |
| Oct. 1, 2024 | Carruthers Wendy | EVP, Human Resources | M | Stock Option (Right to Buy) | 1197 | $0.00 | 15,577.0000 | 1,487,400,000 | 7.14% | 0.00% |
| Sept. 5, 2024 | Mahoney Michael F | Chairman, President & CEO | M | Stock Option (Right to Buy) | 56211 | $0.00 | 281,057.0000 | 1,463,500,000 | 16.67% | 0.00% |
| Sept. 5, 2024 | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 56211 | $17.26 | 1,939,367.0000 | 1,463,500,000 | 2.98% | 0.00% |
| Sept. 5, 2024 | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 55675 | $16.31 | 1,995,042.0000 | 1,463,500,000 | 2.87% | 0.00% |
| Sept. 5, 2024 | Mahoney Michael F | Chairman, President & CEO | S | Common Stock | 162777 | $81.17 | 1,832,265.0000 | 1,463,500,000 | 8.16% | 0.01% |
| Sept. 5, 2024 | Mahoney Michael F | Chairman, President & CEO | M | Stock Option (Right to Buy) | 55675 | $0.00 | 111,351.0000 | 1,463,500,000 | 33.33% | 0.00% |
| Sept. 3, 2024 | Carruthers Wendy | EVP, Human Resources | M | Stock Option (Right to Buy) | 1197 | $0.00 | 16,774.0000 | 1,463,500,000 | 6.66% | 0.00% |
| Aug. 30, 2024 | Mahoney Michael F | Chairman, President & CEO | G | Common Stock | 176245 | $0.00 | 1,883,156.0000 | 1,463,500,000 | 8.56% | 0.01% |
| Aug. 30, 2024 | Mahoney Michael F | Chairman, President & CEO | G | Common Stock | 95041 | $0.00 | 2,059,401.0000 | 1,463,500,000 | 4.84% | 0.01% |
| Aug. 30, 2024 | Mahoney Michael F | Chairman, President & CEO | G | Common Stock | 114237 | $0.00 | 1,964,360.0000 | 1,463,500,000 | 6.17% | 0.01% |
| Sept. 3, 2024 | Carruthers Wendy | EVP, Human Resources | M | Stock Option (Right to Buy) | 3066 | $0.00 | 9,198.0000 | 1,463,500,000 | 25.00% | 0.00% |
| Sept. 3, 2024 | Carruthers Wendy | EVP, Human Resources | S | Common Stock | 6983 | $81.70 | 37,468.0000 | 1,463,500,000 | 15.71% | 0.00% |
| Sept. 3, 2024 | Carruthers Wendy | EVP, Human Resources | M | Common Stock | 1197 | $24.55 | 44,451.0000 | 1,463,500,000 | 2.77% | 0.00% |
| Sept. 3, 2024 | Carruthers Wendy | EVP, Human Resources | M | Common Stock | 3066 | $17.26 | 43,254.0000 | 1,463,500,000 | 7.63% | 0.00% |
| Aug. 28, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | S | Common Stock | 14132 | $80.00 | 181,249.0000 | 1,463,500,000 | 7.23% | 0.00% |
| Aug. 26, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 3176 | $22.71 | 37,186.0000 | 1,463,500,000 | 9.34% | 0.00% |
| Aug. 26, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 1009 | $17.26 | 38,195.0000 | 1,463,500,000 | 2.71% | 0.00% |
| Aug. 26, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Stock Option (Right to Buy) | 3176 | $0.00 | 15,883.0000 | 1,463,500,000 | 16.66% | 0.00% |
| Aug. 26, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | S | Common Stock | 14012 | $79.25 | 24,183.0000 | 1,463,500,000 | 36.69% | 0.00% |
| Aug. 26, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Stock Option (Right to Buy) | 1009 | $0.00 | 5,045.0000 | 1,463,500,000 | 16.67% | 0.00% |
| Aug. 6, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | I | Common Stock | 10843 | $73.76 | 34,010.0000 | 1,463,500,000 | 46.80% | 0.00% |
| Aug. 1, 2024 | Habiger David C | Director | A | Common Stock | 2155 | $0.00 | 2,295.0000 | 1,463,500,000 | 1539.29% | 0.00% |
| Aug. 1, 2024 | Habiger David C | Director | A | Common Stock | 1252 | $0.00 | 3,547.0000 | 1,463,500,000 | 54.55% | 0.00% |
| Aug. 1, 2024 | Carruthers Wendy | EVP, Human Resources | M | Stock Option (Right to Buy) | 3066 | $0.00 | 12,264.0000 | 1,463,500,000 | 20.00% | 0.00% |
| Aug. 1, 2024 | Carruthers Wendy | EVP, Human Resources | M | Common Stock | 3066 | $17.26 | 45,974.0000 | 1,463,500,000 | 7.15% | 0.00% |
| Aug. 1, 2024 | Carruthers Wendy | EVP, Human Resources | M | Common Stock | 1197 | $24.55 | 47,171.0000 | 1,463,500,000 | 2.60% | 0.00% |
| Aug. 1, 2024 | Carruthers Wendy | EVP, Human Resources | S | Common Stock | 6983 | $74.12 | 40,188.0000 | 1,463,500,000 | 14.80% | 0.00% |
| Aug. 1, 2024 | Carruthers Wendy | EVP, Human Resources | M | Stock Option (Right to Buy) | 1197 | $0.00 | 17,971.0000 | 1,463,500,000 | 6.24% | 0.00% |
| July 1, 2024 | Carruthers Wendy | EVP, Human Resources | M | Stock Option (Right to Buy) | 3066 | $0.00 | 15,330.0000 | 1,463,500,000 | 16.67% | 0.00% |
| July 1, 2024 | Brown Vance R | SVP, GC and Corp. Secretary | M | Common Stock | 4036 | $0.00 | 36,362.0000 | 1,463,500,000 | 12.49% | 0.00% |
| July 1, 2024 | Brown Vance R | SVP, GC and Corp. Secretary | F | Common Stock | 1952 | $76.41 | 34,410.0000 | 1,463,500,000 | 5.37% | 0.00% |
| July 1, 2024 | Brown Vance R | SVP, GC and Corp. Secretary | M | Restricted Stock Units | 4036 | $0.00 | 4,036.0000 | 1,463,500,000 | 50.00% | 0.00% |
| July 1, 2024 | Carruthers Wendy | EVP, Human Resources | M | Common Stock | 3066 | $17.26 | 48,694.0000 | 1,463,500,000 | 6.72% | 0.00% |
| July 1, 2024 | Carruthers Wendy | EVP, Human Resources | M | Common Stock | 1197 | $24.55 | 49,891.0000 | 1,463,500,000 | 2.46% | 0.00% |
| July 1, 2024 | Carruthers Wendy | EVP, Human Resources | S | Common Stock | 6983 | $77.30 | 42,908.0000 | 1,463,500,000 | 14.00% | 0.00% |
| July 1, 2024 | Carruthers Wendy | EVP, Human Resources | M | Stock Option (Right to Buy) | 1197 | $0.00 | 19,168.0000 | 1,463,500,000 | 5.88% | 0.00% |
| June 3, 2024 | Pegus Cheryl | Director | A | Deferred Stock Units | 2800 | $0.00 | 2,800.0000 | 1,463,500,000 | 9999.99% | 0.00% |
| June 3, 2024 | Pegus Cheryl | Director | A | Deferred Stock Units | 407 | $0.00 | 3,207.0000 | 1,463,500,000 | 14.54% | 0.00% |
| June 3, 2024 | Carruthers Wendy | EVP, Human Resources | S | Common Stock | 6983 | $75.33 | 45,628.0000 | 1,463,500,000 | 13.27% | 0.00% |
| June 3, 2024 | Carruthers Wendy | EVP, Human Resources | M | Common Stock | 3066 | $17.26 | 51,414.0000 | 1,463,500,000 | 6.34% | 0.00% |
| June 3, 2024 | Carruthers Wendy | EVP, Human Resources | M | Common Stock | 1197 | $24.55 | 52,611.0000 | 1,463,500,000 | 2.33% | 0.00% |
| June 3, 2024 | Carruthers Wendy | EVP, Human Resources | M | Stock Option (Right to Buy) | 3066 | $0.00 | 18,396.0000 | 1,463,500,000 | 14.29% | 0.00% |
| June 3, 2024 | Carruthers Wendy | EVP, Human Resources | M | Stock Option (Right to Buy) | 1197 | $0.00 | 20,365.0000 | 1,463,500,000 | 5.55% | 0.00% |
| May 29, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | S | Common Stock | 63802 | $75.10 | 28,022.0000 | 1,463,500,000 | 69.48% | 0.00% |
| May 29, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Stock Option (Right to Buy) | 33726 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| May 29, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Common Stock | 33726 | $17.26 | 91,824.0000 | 1,463,500,000 | 58.05% | 0.00% |
| May 28, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 1009 | $17.26 | 36,747.0000 | 1,463,500,000 | 2.82% | 0.00% |
| May 28, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | S | Common Stock | 14011 | $75.34 | 22,736.0000 | 1,463,500,000 | 38.13% | 0.00% |
| May 28, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Stock Option (Right to Buy) | 1009 | $0.00 | 6,054.0000 | 1,463,500,000 | 14.29% | 0.00% |
| May 28, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Stock Option (Right to Buy) | 3177 | $0.00 | 19,059.0000 | 1,463,500,000 | 14.29% | 0.00% |
| May 28, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 3177 | $22.71 | 35,738.0000 | 1,463,500,000 | 9.76% | 0.00% |
| May 22, 2024 | Brennan Daniel J. | EVP and CFO | M | Stock Option (Right to Buy) | 16863 | $0.00 | 16,865.0000 | 1,463,500,000 | 50.00% | 0.00% |
| May 22, 2024 | Brennan Daniel J. | EVP and CFO | M | Stock Option (Right to Buy) | 15086 | $0.00 | 15,087.0000 | 1,463,500,000 | 50.00% | 0.00% |
| May 22, 2024 | Brown Vance R | SVP, GC and Corp. Secretary | M | Common Stock | 15006 | $27.09 | 47,332.0000 | 1,463,500,000 | 46.42% | 0.00% |
| May 22, 2024 | Brennan Daniel J. | EVP and CFO | M | Common Stock | 16863 | $24.55 | 288,405.0000 | 1,463,500,000 | 6.21% | 0.00% |
| May 22, 2024 | Brennan Daniel J. | EVP and CFO | M | Common Stock | 16863 | $17.26 | 305,268.0000 | 1,463,500,000 | 5.85% | 0.00% |
| May 22, 2024 | Brennan Daniel J. | EVP and CFO | M | Common Stock | 15642 | $27.09 | 320,910.0000 | 1,463,500,000 | 5.12% | 0.00% |
| May 22, 2024 | Brennan Daniel J. | EVP and CFO | M | Common Stock | 15086 | $16.31 | 335,996.0000 | 1,463,500,000 | 4.70% | 0.00% |
| May 22, 2024 | Brennan Daniel J. | EVP and CFO | S | Common Stock | 64454 | $75.91 | 271,542.0000 | 1,463,500,000 | 19.18% | 0.00% |
| May 23, 2024 | Brennan Daniel J. | EVP and CFO | S | Common Stock | 47621 | $75.11 | 223,921.0000 | 1,463,500,000 | 17.54% | 0.00% |
| May 22, 2024 | Brennan Daniel J. | EVP and CFO | M | Stock Option (Right to Buy) | 15642 | $0.00 | 46,927.0000 | 1,463,500,000 | 25.00% | 0.00% |
| May 22, 2024 | Brown Vance R | SVP, GC and Corp. Secretary | S | Common Stock | 15006 | $76.01 | 32,326.0000 | 1,463,500,000 | 31.70% | 0.00% |
| May 22, 2024 | Brennan Daniel J. | EVP and CFO | M | Stock Option (Right to Buy) | 16863 | $0.00 | 55,600.0000 | 1,463,500,000 | 23.27% | 0.00% |
| May 21, 2024 | Brown Vance R | SVP, GC and Corp. Secretary | M | Common Stock | 18037 | $24.55 | 50,363.0000 | 1,463,500,000 | 55.80% | 0.00% |
| May 21, 2024 | Brown Vance R | SVP, GC and Corp. Secretary | S | Common Stock | 18037 | $75.60 | 32,326.0000 | 1,463,500,000 | 35.81% | 0.00% |
| May 22, 2024 | Brown Vance R | SVP, GC and Corp. Secretary | M | Stock Option (Right to Buy) | 15006 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| May 21, 2024 | Brown Vance R | SVP, GC and Corp. Secretary | M | Stock Option (Right to Buy) | 18037 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| May 13, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | G | Common Stock | 2380 | $0.00 | 195,381.0000 | 1,463,500,000 | 1.20% | 0.00% |
| May 9, 2024 | Zane Ellen M | Director | A | Common Stock | 2901 | $0.00 | 48,530.0000 | 1,463,500,000 | 6.36% | 0.00% |
| May 10, 2024 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr | M | Common Stock | 12931 | $16.31 | 44,352.9900 | 1,463,500,000 | 41.15% | 0.00% |
| May 10, 2024 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr | S | Common Stock | 12931 | $74.14 | 31,421.9900 | 1,463,500,000 | 29.15% | 0.00% |
| May 10, 2024 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr | M | Stock Option (Right to Buy) | 12931 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| May 9, 2024 | WICHMANN DAVID S | Director | A | Common Stock | 2901 | $0.00 | 39,501.0000 | 1,463,500,000 | 7.93% | 0.00% |
| May 9, 2024 | Sununu John E | Director | A | Common Stock | 2901 | $0.00 | 52,642.0000 | 1,463,500,000 | 5.83% | 0.00% |
| May 9, 2024 | Mega Jessica L | Director | A | Common Stock | 2901 | $0.00 | 6,154.0000 | 1,463,500,000 | 89.18% | 0.00% |
| May 9, 2024 | LUDWIG EDWARD J | Director | A | Common Stock | 2901 | $0.00 | 44,275.0000 | 1,463,500,000 | 7.01% | 0.00% |
| May 9, 2024 | Morano Susan E | Director | A | Common Stock | 1450 | $0.00 | 3,532.0000 | 1,463,500,000 | 69.64% | 0.00% |
| May 9, 2024 | Morano Susan E | Director | A | Common Stock | 421 | $0.00 | 3,953.0000 | 1,463,500,000 | 11.92% | 0.00% |
| May 9, 2024 | Morano Susan E | Director | A | Deferred Stock Units | 1450 | $0.00 | 3,532.0000 | 1,463,500,000 | 69.64% | 0.00% |
| May 9, 2024 | Morano Susan E | Director | A | Deferred Stock Units | 421 | $0.00 | 3,953.0000 | 1,463,500,000 | 11.92% | 0.00% |
| May 9, 2024 | FUJIMORI YOSHIAKI | Director | A | Common Stock | 2901 | $0.00 | 2,901.0000 | 1,463,500,000 | 9999.99% | 0.00% |
| May 9, 2024 | Dockendorff Charles J | Director | A | Common Stock | 2901 | $0.00 | 62,903.0000 | 1,463,500,000 | 4.83% | 0.00% |
| May 7, 2024 | Dockendorff Charles J | Director | S | Common Stock | 3946 | $72.70 | 60,002.0000 | 1,463,500,000 | 6.17% | 0.00% |
| May 2, 2024 | Sorenson John Bradley | EVP, Global Operations | M | Common Stock | 4203 | $0.00 | 54,841.0000 | 1,463,500,000 | 8.30% | 0.00% |
| May 2, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Restricted Stock Units | 2102 | $0.00 | 4,204.0000 | 1,463,500,000 | 33.33% | 0.00% |
| May 2, 2024 | Sorenson John Bradley | EVP, Global Operations | M | Restricted Stock Units | 4203 | $0.00 | 8,408.0000 | 1,463,500,000 | 33.33% | 0.00% |
| May 2, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 2102 | $0.00 | 33,578.0000 | 1,463,500,000 | 6.68% | 0.00% |
| May 2, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | F | Common Stock | 1017 | $72.03 | 32,561.0000 | 1,463,500,000 | 3.03% | 0.00% |
| May 2, 2024 | Sorenson John Bradley | EVP, Global Operations | F | Common Stock | 1917 | $72.03 | 52,924.0000 | 1,463,500,000 | 3.50% | 0.00% |
| May 1, 2024 | Carruthers Wendy | EVP, Human Resources | M | Stock Option (Right to Buy) | 3066 | $0.00 | 21,462.0000 | 1,463,500,000 | 12.50% | 0.00% |
| May 1, 2024 | Carruthers Wendy | EVP, Human Resources | S | Common Stock | 6983 | $71.47 | 48,348.0000 | 1,463,500,000 | 12.62% | 0.00% |
| May 1, 2024 | Carruthers Wendy | EVP, Human Resources | M | Stock Option (Right to Buy) | 1197 | $0.00 | 21,562.0000 | 1,463,500,000 | 5.26% | 0.00% |
| May 1, 2024 | Sorenson John Bradley | EVP, Global Operations | M | Common Stock | 17587 | $17.26 | 68,225.0000 | 1,463,500,000 | 34.73% | 0.00% |
| May 1, 2024 | Sorenson John Bradley | EVP, Global Operations | S | Common Stock | 17587 | $71.50 | 50,638.0000 | 1,463,500,000 | 25.78% | 0.00% |
| May 1, 2024 | Sorenson John Bradley | EVP, Global Operations | M | Stock Option (Right to Buy) | 17587 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| May 1, 2024 | Carruthers Wendy | EVP, Human Resources | M | Common Stock | 3066 | $17.26 | 54,134.0000 | 1,463,500,000 | 6.00% | 0.00% |
| May 1, 2024 | Carruthers Wendy | EVP, Human Resources | M | Common Stock | 1197 | $24.55 | 55,331.0000 | 1,463,500,000 | 2.21% | 0.00% |
| April 26, 2024 | LUDWIG EDWARD J | Director | M | Common Stock | 9818 | $17.37 | 51,192.0000 | 1,463,500,000 | 23.73% | 0.00% |
| April 26, 2024 | LUDWIG EDWARD J | Director | M | Stock Option (Right to Buy) | 9818 | $17.37 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| April 26, 2024 | LUDWIG EDWARD J | Director | S | Common Stock | 9818 | $73.29 | 41,374.0000 | 1,463,500,000 | 19.18% | 0.00% |
| April 1, 2024 | Carruthers Wendy | EVP, Human Resources | M | Common Stock | 3066 | $17.26 | 56,854.0000 | 1,463,500,000 | 5.70% | 0.00% |
| April 1, 2024 | Sorenson John Bradley | EVP, Global Operations | M | Common Stock | 16351 | $16.31 | 66,989.0000 | 1,463,500,000 | 32.29% | 0.00% |
| April 1, 2024 | Sorenson John Bradley | EVP, Global Operations | S | Common Stock | 16351 | $69.30 | 50,638.0000 | 1,463,500,000 | 24.41% | 0.00% |
| April 1, 2024 | Sorenson John Bradley | EVP, Global Operations | M | Stock Option (Right to Buy) | 16351 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| April 1, 2024 | Carruthers Wendy | EVP, Human Resources | M | Common Stock | 1197 | $24.55 | 58,051.0000 | 1,463,500,000 | 2.11% | 0.00% |
| April 1, 2024 | Carruthers Wendy | EVP, Human Resources | S | Common Stock | 6983 | $68.42 | 51,068.0000 | 1,463,500,000 | 12.03% | 0.00% |
| April 1, 2024 | Carruthers Wendy | EVP, Human Resources | M | Stock Option (Right to Buy) | 3066 | $0.00 | 24,528.0000 | 1,463,500,000 | 11.11% | 0.00% |
| April 1, 2024 | Carruthers Wendy | EVP, Human Resources | M | Stock Option (Right to Buy) | 1197 | $0.00 | 22,759.0000 | 1,463,500,000 | 5.00% | 0.00% |
| March 18, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | S | Common Stock | 14506 | $66.45 | 58,098.0000 | 1,463,500,000 | 19.98% | 0.00% |
| Feb. 14, 2024 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr | F | Common Stock | 0 | $65.95 | 28,575.9900 | 1,463,500,000 | 0.00% | 0.00% |
| March 1, 2024 | Woodworth Emily | SVP, Global Controller and CAO | A | Stock Option (Right to Buy) | 3421 | $0.00 | 3,421.0000 | 1,463,500,000 | 9999.99% | 0.00% |
| March 1, 2024 | Woodworth Emily | SVP, Global Controller and CAO | A | Restricted Stock Units | 3351 | $0.00 | 3,351.0000 | 1,463,500,000 | 9999.99% | 0.00% |
| March 1, 2024 | Carruthers Wendy | EVP, Human Resources | S | Common Stock | 6983 | $66.35 | 53,788.0000 | 1,463,500,000 | 11.49% | 0.00% |
| March 1, 2024 | Carruthers Wendy | EVP, Human Resources | M | Common Stock | 3066 | $17.26 | 59,574.0000 | 1,463,500,000 | 5.43% | 0.00% |
| March 1, 2024 | Carruthers Wendy | EVP, Human Resources | M | Common Stock | 1197 | $24.55 | 60,771.0000 | 1,463,500,000 | 2.01% | 0.00% |
| March 1, 2024 | Carruthers Wendy | EVP, Human Resources | M | Stock Option (Right to Buy) | 3066 | $0.00 | 27,594.0000 | 1,463,500,000 | 10.00% | 0.00% |
| March 1, 2024 | Carruthers Wendy | EVP, Human Resources | M | Stock Option (Right to Buy) | 1197 | $0.00 | 23,956.0000 | 1,463,500,000 | 4.76% | 0.00% |
| Feb. 26, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Stock Option (Right to Buy) | 1009 | $0.00 | 7,063.0000 | 1,463,500,000 | 12.50% | 0.00% |
| Feb. 26, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 3176 | $22.71 | 39,805.0000 | 1,463,500,000 | 8.67% | 0.00% |
| Feb. 26, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 1009 | $17.26 | 40,814.0000 | 1,463,500,000 | 2.53% | 0.00% |
| Feb. 26, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Stock Option (Right to Buy) | 3176 | $0.00 | 22,236.0000 | 1,463,500,000 | 12.50% | 0.00% |
| Feb. 26, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | S | Common Stock | 9335 | $67.07 | 31,479.0000 | 1,463,500,000 | 22.87% | 0.00% |
| Feb. 23, 2024 | Carruthers Wendy | EVP, Human Resources | M | Stock Option (Right to Buy) | 3066 | $0.00 | 30,660.0000 | 1,463,500,000 | 9.09% | 0.00% |
| Feb. 23, 2024 | Carruthers Wendy | EVP, Human Resources | S | Common Stock | 6983 | $66.89 | 56,508.0000 | 1,463,500,000 | 11.00% | 0.00% |
| Feb. 23, 2024 | Carruthers Wendy | EVP, Human Resources | M | Stock Option (Right to Buy) | 1197 | $0.00 | 25,153.0000 | 1,463,500,000 | 4.54% | 0.00% |
| Feb. 23, 2024 | Carruthers Wendy | EVP, Human Resources | M | Common Stock | 3066 | $17.26 | 62,294.0000 | 1,463,500,000 | 5.18% | 0.00% |
| Feb. 23, 2024 | Carruthers Wendy | EVP, Human Resources | M | Common Stock | 1197 | $24.55 | 63,491.0000 | 1,463,500,000 | 1.92% | 0.00% |
| Feb. 21, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | S | Common Stock | 4960 | $66.35 | 72,604.0000 | 1,463,500,000 | 6.39% | 0.00% |
| Feb. 20, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | I | Common Stock | 67974 | $66.22 | 197,761.0000 | 1,463,500,000 | 25.58% | 0.00% |
| Feb. 16, 2024 | Sorenson John Bradley | EVP, Global Operations | F | Common Stock | 581 | $65.82 | 49,178.0000 | 1,463,500,000 | 1.17% | 0.00% |
| Feb. 18, 2024 | Brown Vance R | SVP, GC and Corp. Secretary | M | Deferred Stock Units | 741 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| Feb. 17, 2024 | Brown Vance R | SVP, GC and Corp. Secretary | M | Restricted Stock Units | 1000 | $0.00 | 1,000.0000 | 1,463,500,000 | 50.00% | 0.00% |
| Feb. 16, 2024 | Brown Vance R | SVP, GC and Corp. Secretary | M | Restricted Stock Units | 1838 | $0.00 | 3,678.0000 | 1,463,500,000 | 33.32% | 0.00% |
| Feb. 18, 2024 | Brown Vance R | SVP, GC and Corp. Secretary | F | Common Stock | 218 | $65.82 | 32,326.0000 | 1,463,500,000 | 0.67% | 0.00% |
| Feb. 18, 2024 | Brown Vance R | SVP, GC and Corp. Secretary | M | Common Stock | 741 | $0.00 | 32,544.0000 | 1,463,500,000 | 2.33% | 0.00% |
| Feb. 17, 2024 | Brown Vance R | SVP, GC and Corp. Secretary | F | Common Stock | 294 | $65.82 | 31,803.0000 | 1,463,500,000 | 0.92% | 0.00% |
| Feb. 17, 2024 | Brown Vance R | SVP, GC and Corp. Secretary | M | Common Stock | 1000 | $0.00 | 32,097.0000 | 1,463,500,000 | 3.22% | 0.00% |
| Feb. 16, 2024 | Brown Vance R | SVP, GC and Corp. Secretary | F | Common Stock | 540 | $65.82 | 31,097.0000 | 1,463,500,000 | 1.71% | 0.00% |
| Feb. 16, 2024 | Brown Vance R | SVP, GC and Corp. Secretary | M | Common Stock | 1838 | $0.00 | 31,637.0000 | 1,463,500,000 | 6.17% | 0.00% |
| Feb. 18, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Deferred Stock Units | 3706 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| Feb. 17, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Restricted Stock Units | 4167 | $0.00 | 4,167.0000 | 1,463,500,000 | 50.00% | 0.00% |
| Feb. 16, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Restricted Stock Units | 3960 | $0.00 | 7,920.0000 | 1,463,500,000 | 33.33% | 0.00% |
| Feb. 18, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 1829 | $65.82 | 265,735.0000 | 1,463,500,000 | 0.68% | 0.00% |
| Feb. 18, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 3706 | $0.00 | 267,564.0000 | 1,463,500,000 | 1.40% | 0.00% |
| Feb. 17, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 2057 | $65.82 | 263,858.0000 | 1,463,500,000 | 0.77% | 0.00% |
| Feb. 17, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 4167 | $0.00 | 265,915.0000 | 1,463,500,000 | 1.59% | 0.00% |
| Feb. 16, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 1806 | $65.82 | 261,748.0000 | 1,463,500,000 | 0.69% | 0.00% |
| Feb. 16, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 3960 | $0.00 | 263,554.0000 | 1,463,500,000 | 1.53% | 0.00% |
| Feb. 20, 2024 | Brennan Daniel J. | EVP and CFO | M | Stock Option (Right to Buy) | 13662 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| Feb. 18, 2024 | Brennan Daniel J. | EVP and CFO | M | Deferred Stock Units | 3706 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| Feb. 17, 2024 | Brennan Daniel J. | EVP and CFO | M | Restricted Stock Units | 4583 | $0.00 | 4,584.0000 | 1,463,500,000 | 49.99% | 0.00% |
| Feb. 16, 2024 | Brennan Daniel J. | EVP and CFO | M | Restricted Stock Units | 4243 | $0.00 | 8,486.0000 | 1,463,500,000 | 33.33% | 0.00% |
| Feb. 20, 2024 | Brennan Daniel J. | EVP and CFO | S | Common Stock | 13662 | $65.86 | 271,542.0000 | 1,463,500,000 | 4.79% | 0.00% |
| Feb. 20, 2024 | Brennan Daniel J. | EVP and CFO | M | Common Stock | 13662 | $13.08 | 285,204.0000 | 1,463,500,000 | 5.03% | 0.00% |
| Feb. 18, 2024 | Brennan Daniel J. | EVP and CFO | F | Common Stock | 1644 | $65.82 | 271,542.0000 | 1,463,500,000 | 0.60% | 0.00% |
| Feb. 18, 2024 | Brennan Daniel J. | EVP and CFO | M | Common Stock | 3706 | $0.00 | 273,186.0000 | 1,463,500,000 | 1.38% | 0.00% |
| Feb. 17, 2024 | Brennan Daniel J. | EVP and CFO | F | Common Stock | 2033 | $65.82 | 269,480.0000 | 1,463,500,000 | 0.75% | 0.00% |
| Feb. 16, 2024 | Brennan Daniel J. | EVP and CFO | F | Common Stock | 1882 | $65.82 | 266,930.0000 | 1,463,500,000 | 0.70% | 0.00% |
| Feb. 16, 2024 | Brennan Daniel J. | EVP and CFO | M | Common Stock | 4243 | $0.00 | 268,812.0000 | 1,463,500,000 | 1.60% | 0.00% |
| Feb. 18, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Deferred Stock Units | 2372 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| Feb. 17, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Restricted Stock Units | 2833 | $0.00 | 2,834.0000 | 1,463,500,000 | 49.99% | 0.00% |
| Feb. 16, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Restricted Stock Units | 2546 | $0.00 | 5,092.0000 | 1,463,500,000 | 33.33% | 0.00% |
| Feb. 18, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | F | Common Stock | 1052 | $65.82 | 36,629.0000 | 1,463,500,000 | 2.79% | 0.00% |
| Feb. 18, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 2372 | $0.00 | 37,681.0000 | 1,463,500,000 | 6.72% | 0.00% |
| Feb. 17, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | F | Common Stock | 1257 | $65.82 | 35,309.0000 | 1,463,500,000 | 3.44% | 0.00% |
| Feb. 17, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 2833 | $0.00 | 36,566.0000 | 1,463,500,000 | 8.40% | 0.00% |
| Feb. 16, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | F | Common Stock | 1130 | $65.82 | 33,733.0000 | 1,463,500,000 | 3.24% | 0.00% |
| Feb. 16, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 2546 | $0.00 | 34,863.0000 | 1,463,500,000 | 7.88% | 0.00% |
| Feb. 18, 2024 | Mahoney Michael F | Chairman, President & CEO | M | Deferred Stock Units | 16307 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| Feb. 17, 2024 | Mahoney Michael F | Chairman, President & CEO | M | Restricted Stock Units | 18333 | $0.00 | 18,334.0000 | 1,463,500,000 | 50.00% | 0.00% |
| Feb. 16, 2024 | Mahoney Michael F | Chairman, President & CEO | M | Restricted Stock Units | 16265 | $0.00 | 32,530.0000 | 1,463,500,000 | 33.33% | 0.00% |
| Feb. 18, 2024 | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 7233 | $65.82 | 1,850,123.0000 | 1,463,500,000 | 0.39% | 0.00% |
| Feb. 18, 2024 | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 16307 | $0.00 | 1,857,356.0000 | 1,463,500,000 | 0.89% | 0.00% |
| Feb. 17, 2024 | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 8131 | $65.82 | 1,841,049.0000 | 1,463,500,000 | 0.44% | 0.00% |
| Feb. 17, 2024 | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 18333 | $0.00 | 1,849,180.0000 | 1,463,500,000 | 1.00% | 0.00% |
| Feb. 16, 2024 | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 7214 | $65.82 | 1,830,847.0000 | 1,463,500,000 | 0.39% | 0.00% |
| Feb. 16, 2024 | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 16265 | $0.00 | 1,838,061.0000 | 1,463,500,000 | 0.89% | 0.00% |
| Feb. 18, 2024 | Carruthers Wendy | EVP, Human Resources | M | Deferred Stock Units | 1853 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| Feb. 17, 2024 | Carruthers Wendy | EVP, Human Resources | M | Restricted Stock Units | 2250 | $0.00 | 2,250.0000 | 1,463,500,000 | 50.00% | 0.00% |
| Feb. 16, 2024 | Carruthers Wendy | EVP, Human Resources | M | Restricted Stock Units | 2051 | $0.00 | 4,102.0000 | 1,463,500,000 | 33.33% | 0.00% |
| Feb. 20, 2024 | Carruthers Wendy | EVP, Human Resources | G | Common Stock | 3050 | $0.00 | 59,228.0000 | 1,463,500,000 | 4.90% | 0.00% |
| Feb. 18, 2024 | Carruthers Wendy | EVP, Human Resources | F | Common Stock | 822 | $65.82 | 62,278.0000 | 1,463,500,000 | 1.30% | 0.00% |
| Feb. 18, 2024 | Carruthers Wendy | EVP, Human Resources | M | Common Stock | 1853 | $0.00 | 63,100.0000 | 1,463,500,000 | 3.03% | 0.00% |
| Feb. 17, 2024 | Carruthers Wendy | EVP, Human Resources | F | Common Stock | 998 | $65.82 | 61,247.0000 | 1,463,500,000 | 1.60% | 0.00% |
| Feb. 17, 2024 | Carruthers Wendy | EVP, Human Resources | M | Common Stock | 2250 | $0.00 | 62,245.0000 | 1,463,500,000 | 3.75% | 0.00% |
| Feb. 16, 2024 | Carruthers Wendy | EVP, Human Resources | F | Common Stock | 910 | $65.82 | 59,995.0000 | 1,463,500,000 | 1.49% | 0.00% |
| Feb. 16, 2024 | Carruthers Wendy | EVP, Human Resources | M | Common Stock | 2051 | $0.00 | 60,905.0000 | 1,463,500,000 | 3.48% | 0.00% |
| Feb. 18, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Deferred Stock Units | 2817 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| Feb. 17, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Restricted Stock Units | 3333 | $0.00 | 3,334.0000 | 1,463,500,000 | 49.99% | 0.00% |
| Feb. 16, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Restricted Stock Units | 2970 | $0.00 | 5,940.0000 | 1,463,500,000 | 33.33% | 0.00% |
| Feb. 18, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | F | Common Stock | 1285 | $65.82 | 77,564.0000 | 1,463,500,000 | 1.63% | 0.00% |
| Feb. 18, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Common Stock | 2817 | $0.00 | 78,849.0000 | 1,463,500,000 | 3.71% | 0.00% |
| Feb. 17, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | F | Common Stock | 1520 | $65.82 | 76,032.0000 | 1,463,500,000 | 1.96% | 0.00% |
| Feb. 17, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Common Stock | 3333 | $0.00 | 77,552.0000 | 1,463,500,000 | 4.49% | 0.00% |
| Feb. 16, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | F | Common Stock | 1355 | $65.82 | 74,219.0000 | 1,463,500,000 | 1.79% | 0.00% |
| Feb. 16, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Common Stock | 2970 | $0.00 | 75,574.0000 | 1,463,500,000 | 4.09% | 0.00% |
| Feb. 18, 2024 | Monson Jonathan | SVP, Global Controller and CAO | M | Deferred Stock Units | 638 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| Feb. 17, 2024 | Monson Jonathan | SVP, Global Controller and CAO | M | Restricted Stock Units | 1000 | $0.00 | 1,000.0000 | 1,463,500,000 | 50.00% | 0.00% |
| Feb. 16, 2024 | Monson Jonathan | SVP, Global Controller and CAO | M | Restricted Stock Units | 990 | $0.00 | 1,980.0000 | 1,463,500,000 | 33.33% | 0.00% |
| Feb. 18, 2024 | Monson Jonathan | SVP, Global Controller and CAO | F | Common Stock | 258 | $65.82 | 37,982.0000 | 1,463,500,000 | 0.67% | 0.00% |
| Feb. 18, 2024 | Monson Jonathan | SVP, Global Controller and CAO | M | Common Stock | 638 | $0.00 | 38,240.0000 | 1,463,500,000 | 1.70% | 0.00% |
| Feb. 17, 2024 | Brennan Daniel J. | EVP and CFO | M | Common Stock | 4583 | $0.00 | 271,513.0000 | 1,463,500,000 | 1.72% | 0.00% |
| Feb. 17, 2024 | Monson Jonathan | SVP, Global Controller and CAO | F | Common Stock | 404 | $65.82 | 37,602.0000 | 1,463,500,000 | 1.06% | 0.00% |
| Feb. 17, 2024 | Monson Jonathan | SVP, Global Controller and CAO | M | Common Stock | 1000 | $0.00 | 38,006.0000 | 1,463,500,000 | 2.70% | 0.00% |
| Feb. 16, 2024 | Monson Jonathan | SVP, Global Controller and CAO | F | Common Stock | 427 | $65.82 | 37,006.0000 | 1,463,500,000 | 1.14% | 0.00% |
| Feb. 16, 2024 | Monson Jonathan | SVP, Global Controller and CAO | M | Common Stock | 990 | $0.00 | 37,433.0000 | 1,463,500,000 | 2.72% | 0.00% |
| Feb. 18, 2024 | Sorenson John Bradley | EVP, Global Operations | M | Deferred Stock Units | 1186 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| Feb. 17, 2024 | Sorenson John Bradley | EVP, Global Operations | M | Restricted Stock Units | 1500 | $0.00 | 1,500.0000 | 1,463,500,000 | 50.00% | 0.00% |
| Feb. 16, 2024 | Sorenson John Bradley | EVP, Global Operations | M | Restricted Stock Units | 1273 | $0.00 | 2,546.0000 | 1,463,500,000 | 33.33% | 0.00% |
| Feb. 18, 2024 | Sorenson John Bradley | EVP, Global Operations | F | Common Stock | 541 | $65.82 | 50,638.0000 | 1,463,500,000 | 1.06% | 0.00% |
| Feb. 18, 2024 | Sorenson John Bradley | EVP, Global Operations | M | Common Stock | 1186 | $0.00 | 51,179.0000 | 1,463,500,000 | 2.37% | 0.00% |
| Feb. 17, 2024 | Sorenson John Bradley | EVP, Global Operations | F | Common Stock | 685 | $65.82 | 49,993.0000 | 1,463,500,000 | 1.35% | 0.00% |
| Feb. 17, 2024 | Sorenson John Bradley | EVP, Global Operations | M | Common Stock | 1500 | $0.00 | 50,678.0000 | 1,463,500,000 | 3.05% | 0.00% |
| Feb. 16, 2024 | Sorenson John Bradley | EVP, Global Operations | M | Common Stock | 1273 | $0.00 | 49,759.0000 | 1,463,500,000 | 2.63% | 0.00% |
| Feb. 17, 2024 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr | M | Restricted Stock Units | 2500 | $0.00 | 2,500.0000 | 1,463,500,000 | 50.00% | 0.00% |
| Feb. 16, 2024 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr | M | Restricted Stock Units | 2263 | $0.00 | 4,526.0000 | 1,463,500,000 | 33.33% | 0.00% |
| Feb. 17, 2024 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr | F | Common Stock | 1448 | $65.82 | 29,201.9900 | 1,463,500,000 | 4.72% | 0.00% |
| Feb. 17, 2024 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr | M | Common Stock | 2500 | $0.00 | 30,649.9900 | 1,463,500,000 | 8.88% | 0.00% |
| Feb. 16, 2024 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr | F | Common Stock | 1311 | $65.82 | 28,149.9900 | 1,463,500,000 | 4.45% | 0.00% |
| Feb. 16, 2024 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr | M | Common Stock | 2263 | $0.00 | 29,460.9900 | 1,463,500,000 | 8.32% | 0.00% |
| Feb. 18, 2024 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr | M | Deferred Stock Units | 2002 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| Feb. 18, 2024 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr | F | Common Stock | 1160 | $65.82 | 30,043.9900 | 1,463,500,000 | 3.72% | 0.00% |
| Feb. 18, 2024 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr | M | Common Stock | 2002 | $0.00 | 31,203.9900 | 1,463,500,000 | 6.86% | 0.00% |
| Feb. 14, 2024 | Brennan Daniel J. | EVP and CFO | F | Common Stock | 1935 | $65.95 | 264,569.0000 | 1,463,500,000 | 0.73% | 0.00% |
| Feb. 14, 2024 | Brennan Daniel J. | EVP and CFO | M | Restricted Stock Units | 4362 | $0.00 | 13,087.0000 | 1,463,500,000 | 25.00% | 0.00% |
| Feb. 14, 2024 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr | M | Common Stock | 2379 | $0.00 | 28,575.9900 | 1,463,500,000 | 9.08% | 0.00% |
| Feb. 14, 2024 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr | F | Common Stock | 1378 | $65.95 | 27,197.9900 | 1,463,500,000 | 4.82% | 0.00% |
| Feb. 14, 2024 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr | M | Restricted Stock Units | 2379 | $0.00 | 7,138.0000 | 1,463,500,000 | 25.00% | 0.00% |
| Feb. 14, 2024 | Sorenson John Bradley | EVP, Global Operations | M | Common Stock | 2115 | $0.00 | 49,451.0000 | 1,463,500,000 | 4.47% | 0.00% |
| Feb. 14, 2024 | Sorenson John Bradley | EVP, Global Operations | F | Common Stock | 965 | $65.95 | 48,486.0000 | 1,463,500,000 | 1.95% | 0.00% |
| Feb. 14, 2024 | Sorenson John Bradley | EVP, Global Operations | M | Restricted Stock Units | 2115 | $0.00 | 6,345.0000 | 1,463,500,000 | 25.00% | 0.00% |
| Feb. 14, 2024 | Monson Jonathan | SVP, Global Controller and CAO | M | Common Stock | 1057 | $0.00 | 36,931.0000 | 1,463,500,000 | 2.95% | 0.00% |
| Feb. 14, 2024 | Monson Jonathan | SVP, Global Controller and CAO | F | Common Stock | 488 | $65.95 | 36,443.0000 | 1,463,500,000 | 1.32% | 0.00% |
| Feb. 14, 2024 | Monson Jonathan | SVP, Global Controller and CAO | M | Restricted Stock Units | 1057 | $0.00 | 3,173.0000 | 1,463,500,000 | 24.99% | 0.00% |
| Feb. 14, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Common Stock | 2776 | $0.00 | 73,870.0000 | 1,463,500,000 | 3.90% | 0.00% |
| Feb. 14, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | F | Common Stock | 1266 | $65.95 | 72,604.0000 | 1,463,500,000 | 1.71% | 0.00% |
| Feb. 14, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Restricted Stock Units | 2776 | $0.00 | 8,328.0000 | 1,463,500,000 | 25.00% | 0.00% |
| Feb. 14, 2024 | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 16523 | $0.00 | 1,829,124.0000 | 1,463,500,000 | 0.91% | 0.00% |
| Feb. 14, 2024 | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 7328 | $65.95 | 1,821,796.0000 | 1,463,500,000 | 0.40% | 0.00% |
| Feb. 14, 2024 | Mahoney Michael F | Chairman, President & CEO | M | Restricted Stock Units | 16523 | $0.00 | 49,572.0000 | 1,463,500,000 | 25.00% | 0.00% |
| Feb. 14, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 4362 | $0.00 | 261,584.0000 | 1,463,500,000 | 1.70% | 0.00% |
| Feb. 14, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 1990 | $65.95 | 259,594.0000 | 1,463,500,000 | 0.76% | 0.00% |
| Feb. 14, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Restricted Stock Units | 4362 | $0.00 | 13,087.0000 | 1,463,500,000 | 25.00% | 0.00% |
| Feb. 14, 2024 | Carruthers Wendy | EVP, Human Resources | M | Common Stock | 2115 | $0.00 | 59,793.0000 | 1,463,500,000 | 3.67% | 0.00% |
| Feb. 14, 2024 | Carruthers Wendy | EVP, Human Resources | F | Common Stock | 939 | $65.95 | 58,854.0000 | 1,463,500,000 | 1.57% | 0.00% |
| Feb. 14, 2024 | Carruthers Wendy | EVP, Human Resources | M | Restricted Stock Units | 2115 | $0.00 | 6,345.0000 | 1,463,500,000 | 25.00% | 0.00% |
| Feb. 14, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 3172 | $0.00 | 33,725.0000 | 1,463,500,000 | 10.38% | 0.00% |
| Feb. 14, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | F | Common Stock | 1408 | $65.95 | 32,317.0000 | 1,463,500,000 | 4.17% | 0.00% |
| Feb. 14, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Restricted Stock Units | 3172 | $0.00 | 9,518.0000 | 1,463,500,000 | 25.00% | 0.00% |
| Feb. 14, 2024 | Brown Vance R | SVP, GC and Corp. Secretary | M | Common Stock | 1850 | $0.00 | 30,428.0000 | 1,463,500,000 | 6.47% | 0.00% |
| Feb. 14, 2024 | Brown Vance R | SVP, GC and Corp. Secretary | F | Common Stock | 629 | $65.95 | 29,799.0000 | 1,463,500,000 | 2.07% | 0.00% |
| Feb. 14, 2024 | Brown Vance R | SVP, GC and Corp. Secretary | M | Restricted Stock Units | 1850 | $0.00 | 5,552.0000 | 1,463,500,000 | 24.99% | 0.00% |
| Feb. 14, 2024 | Brennan Daniel J. | EVP and CFO | M | Common Stock | 4362 | $0.00 | 266,504.0000 | 1,463,500,000 | 1.66% | 0.00% |
| Feb. 12, 2024 | Monson Jonathan | SVP, Global Controller and CAO | A | Restricted Stock Units | 4616 | $0.00 | 4,616.0000 | 1,463,500,000 | 9999.99% | 0.00% |
| Feb. 13, 2024 | LUDWIG EDWARD J | Director | M | Stock Option (Right to Buy) | 7000 | $0.00 | 9,818.0000 | 1,463,500,000 | 41.62% | 0.00% |
| Feb. 13, 2024 | LUDWIG EDWARD J | Director | M | Common Stock | 7000 | $17.37 | 48,374.0000 | 1,463,500,000 | 16.92% | 0.00% |
| Feb. 12, 2024 | Brennan Daniel J. | EVP and CFO | A | Stock Option (Right to Buy) | 38537 | $0.00 | 38,537.0000 | 1,463,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Brennan Daniel J. | EVP and CFO | A | Restricted Stock Units | 14617 | $0.00 | 14,617.0000 | 1,463,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Brown Vance R | SVP, GC and Corp. Secretary | A | Stock Option (Right to Buy) | 15212 | $0.00 | 15,212.0000 | 1,463,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Brown Vance R | SVP, GC and Corp. Secretary | A | Restricted Stock Units | 5770 | $0.00 | 5,770.0000 | 1,463,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | A | Stock Option (Right to Buy) | 28396 | $0.00 | 28,396.0000 | 1,463,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | A | Restricted Stock Units | 10770 | $0.00 | 10,770.0000 | 1,463,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Carruthers Wendy | EVP, Human Resources | A | Stock Option (Right to Buy) | 18254 | $0.00 | 18,254.0000 | 1,463,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Carruthers Wendy | EVP, Human Resources | A | Restricted Stock Units | 6924 | $0.00 | 6,924.0000 | 1,463,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | A | Stock Option (Right to Buy) | 36509 | $0.00 | 36,509.0000 | 1,463,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | A | Restricted Stock Units | 13848 | $0.00 | 13,848.0000 | 1,463,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | G | Common Stock | 550 | $0.00 | 257,222.0000 | 1,463,500,000 | 0.21% | 0.00% |
| Feb. 12, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | G | Common Stock | 6000 | $0.00 | 257,222.0000 | 1,463,500,000 | 2.28% | 0.00% |
| Feb. 12, 2024 | Mahoney Michael F | Chairman, President & CEO | A | Stock Option (Right to Buy) | 144516 | $0.00 | 144,516.0000 | 1,463,500,000 | 9999.99% | 0.01% |
| Feb. 12, 2024 | Mahoney Michael F | Chairman, President & CEO | A | Restricted Stock Units | 54816 | $0.00 | 54,816.0000 | 1,463,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Sorenson John Bradley | EVP, Global Operations | A | Stock Option (Right to Buy) | 18254 | $0.00 | 18,254.0000 | 1,463,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Sorenson John Bradley | EVP, Global Operations | A | Restricted Stock Units | 6924 | $0.00 | 6,924.0000 | 1,463,500,000 | 9999.99% | 0.00% |
| Feb. 13, 2024 | LUDWIG EDWARD J | Director | S | Common Stock | 7000 | $65.03 | 41,374.0000 | 1,463,500,000 | 14.47% | 0.00% |
| Feb. 12, 2024 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr | A | Stock Option (Right to Buy) | 20282 | $0.00 | 20,282.0000 | 1,463,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | A | Stock Option (Right to Buy) | 22311 | $0.00 | 22,311.0000 | 1,463,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | A | Restricted Stock Units | 8462 | $0.00 | 8,462.0000 | 1,463,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Monson Jonathan | SVP, Global Controller and CAO | A | Stock Option (Right to Buy) | 14180 | $0.00 | 14,180.0000 | 1,463,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr | A | Restricted Stock Units | 7693 | $0.00 | 7,693.0000 | 1,463,500,000 | 9999.99% | 0.00% |
| Feb. 6, 2024 | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 65047 | $0.00 | 1,812,601.0000 | 1,463,500,000 | 3.46% | 0.00% |
| Feb. 6, 2024 | Sorenson John Bradley | EVP, Global Operations | A | Common Stock | 12000 | $0.00 | 52,808.0000 | 1,463,500,000 | 29.41% | 0.00% |
| Feb. 6, 2024 | Sorenson John Bradley | EVP, Global Operations | F | Common Stock | 5472 | $0.00 | 47,336.0000 | 1,463,500,000 | 10.36% | 0.00% |
| Feb. 6, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | A | Common Stock | 26666 | $0.00 | 83,254.0000 | 1,463,500,000 | 47.12% | 0.00% |
| Feb. 6, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | F | Common Stock | 12160 | $0.00 | 71,094.0000 | 1,463,500,000 | 14.61% | 0.00% |
| Feb. 6, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | A | Common Stock | 22666 | $0.00 | 40,275.0000 | 1,463,500,000 | 128.72% | 0.00% |
| Feb. 6, 2024 | Carruthers Wendy | EVP, Human Resources | F | Common Stock | 7983 | $0.00 | 57,678.0000 | 1,463,500,000 | 12.16% | 0.00% |
| Feb. 6, 2024 | Carruthers Wendy | EVP, Human Resources | A | Common Stock | 18000 | $0.00 | 65,661.0000 | 1,463,500,000 | 37.77% | 0.00% |
| Feb. 6, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 16450 | $0.00 | 262,672.0000 | 1,463,500,000 | 5.89% | 0.00% |
| Feb. 6, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | A | Common Stock | 33332 | $0.00 | 279,122.0000 | 1,463,500,000 | 13.56% | 0.00% |
| Feb. 6, 2024 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr | F | Common Stock | 11579 | $0.00 | 26,196.9900 | 1,463,500,000 | 30.65% | 0.00% |
| Feb. 6, 2024 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr | A | Common Stock | 20000 | $0.00 | 37,775.9900 | 1,463,500,000 | 112.51% | 0.00% |
| Feb. 6, 2024 | Mahoney Michael F | Chairman, President & CEO | A | Common Stock | 146666 | $0.00 | 1,877,648.0000 | 1,463,500,000 | 8.47% | 0.01% |
| Feb. 6, 2024 | Brennan Daniel J. | EVP and CFO | F | Common Stock | 16262 | $0.00 | 262,142.0000 | 1,463,500,000 | 5.84% | 0.00% |
| Feb. 6, 2024 | Brennan Daniel J. | EVP and CFO | A | Common Stock | 36666 | $0.00 | 278,404.0000 | 1,463,500,000 | 15.17% | 0.00% |
| Feb. 6, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | F | Common Stock | 9722 | $0.00 | 30,553.0000 | 1,463,500,000 | 24.14% | 0.00% |
| Jan. 12, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | S | Common Stock | 11660 | $60.00 | 245,820.0000 | 1,463,500,000 | 4.53% | 0.00% |
| Jan. 9, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Common Stock | 15172 | $16.31 | 71,760.0000 | 1,463,500,000 | 26.81% | 0.00% |
| Jan. 9, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | S | Common Stock | 15172 | $59.25 | 56,588.0000 | 1,463,500,000 | 21.14% | 0.00% |
| Jan. 9, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Stock Option (Right to Buy) | 15172 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| Jan. 4, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Common Stock | 15000 | $16.31 | 71,588.0000 | 1,463,500,000 | 26.51% | 0.00% |
| Jan. 4, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | S | Common Stock | 15000 | $58.40 | 56,588.0000 | 1,463,500,000 | 20.95% | 0.00% |
| Jan. 4, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Stock Option (Right to Buy) | 15000 | $0.00 | 15,172.0000 | 1,463,500,000 | 49.71% | 0.00% |
| Jan. 3, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | S | Common Stock | 11931 | $57.82 | 56,588.0000 | 1,463,500,000 | 17.41% | 0.00% |
| Jan. 1, 2024 | Sorenson John Bradley | EVP, Global Operations | F | Common Stock | 3729 | $57.81 | 40,808.0000 | 1,463,500,000 | 8.37% | 0.00% |
| Jan. 1, 2024 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr | M | Common Stock | 13080 | $0.00 | 25,348.9900 | 1,463,500,000 | 106.61% | 0.00% |
| Jan. 1, 2024 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr | F | Common Stock | 7573 | $57.81 | 17,775.9900 | 1,463,500,000 | 29.87% | 0.00% |
| Jan. 1, 2024 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr | M | Performance Share Units | 13080 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| Jan. 1, 2024 | Carruthers Wendy | EVP, Human Resources | F | Common Stock | 5380 | $57.81 | 47,661.0000 | 1,463,500,000 | 10.14% | 0.00% |
| Jan. 1, 2024 | Carruthers Wendy | EVP, Human Resources | M | Performance Share Units | 11772 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| Jan. 1, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Common Stock | 14823 | $0.00 | 24,343.0000 | 1,463,500,000 | 155.70% | 0.00% |
| Jan. 1, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | F | Common Stock | 6733 | $57.81 | 17,610.0000 | 1,463,500,000 | 27.66% | 0.00% |
| Jan. 1, 2024 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | Performance Share Units | 14823 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| Jan. 1, 2024 | Brennan Daniel J. | EVP and CFO | M | Common Stock | 23979 | $0.00 | 249,937.0000 | 1,463,500,000 | 10.61% | 0.00% |
| Jan. 1, 2024 | Brennan Daniel J. | EVP and CFO | F | Common Stock | 8199 | $57.81 | 241,738.0000 | 1,463,500,000 | 3.28% | 0.00% |
| Jan. 1, 2024 | Brennan Daniel J. | EVP and CFO | M | Performance Share Units | 23979 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| Jan. 1, 2024 | Sorenson John Bradley | EVP, Global Operations | M | Common Stock | 7848 | $0.00 | 44,537.0000 | 1,463,500,000 | 21.39% | 0.00% |
| Jan. 1, 2024 | Carruthers Wendy | EVP, Human Resources | M | Common Stock | 11772 | $0.00 | 53,041.0000 | 1,463,500,000 | 28.53% | 0.00% |
| Jan. 1, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Performance Share Units | 21799 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| Dec. 29, 2023 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Stock Option (Right to Buy) | 58189 | $0.00 | 0.0000 | 1,439,700,000 | 100.00% | 0.00% |
| Jan. 1, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 10908 | $57.81 | 257,480.0000 | 1,463,500,000 | 4.06% | 0.00% |
| Jan. 1, 2024 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 21799 | $0.00 | 268,388.0000 | 1,463,500,000 | 8.84% | 0.00% |
| Dec. 29, 2023 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | S | Common Stock | 81940 | $57.50 | 246,589.0000 | 1,439,700,000 | 24.94% | 0.01% |
| Dec. 29, 2023 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 58189 | $16.31 | 328,529.0000 | 1,439,700,000 | 21.52% | 0.00% |
| Jan. 1, 2024 | Mahoney Michael F | Chairman, President & CEO | M | Performance Share Units | 95919 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.01% |
| Jan. 1, 2024 | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 40104 | $57.81 | 1,730,982.0000 | 1,463,500,000 | 2.26% | 0.00% |
| Jan. 1, 2024 | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 95919 | $0.00 | 1,771,086.0000 | 1,463,500,000 | 5.73% | 0.01% |
| Jan. 1, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Performance Share Units | 17439 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| Jan. 1, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | F | Common Stock | 5508 | $57.81 | 68,519.0000 | 1,463,500,000 | 7.44% | 0.00% |
| Jan. 1, 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M | Common Stock | 17439 | $0.00 | 74,027.0000 | 1,463,500,000 | 30.82% | 0.00% |
| Jan. 1, 2024 | Sorenson John Bradley | EVP, Global Operations | M | Performance Share Units | 7848 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |